<PAGE> 1
APOGEE, INC.
- --------------------------------------------------------------------------------
FORM 10-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF
the SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1996
APOGEE, INC.
(Exact name of registrant as specified in its charter)
Delaware 13-3605119
- ------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1018 West Ninth Avenue
King of Prussia, Pennsylvania 19406
- ------------------------------ ---------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 610-992-7670
------------
Securities registered pursuant to Section 12(b) of the Act:
Name of each exchange
Title of each class on which registered
- ------------------- -------------------
NONE NONE
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
----------------------------
(Title of class)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period as the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
-- --
Indicate by check mark if disclosure of delinquent filers, pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. ( )
<PAGE> 2
As of March 18, 1997, 9,870,529 shares of Common Stock, $.01 par value,
were outstanding, and the aggregate market value of the shares of Common Stock,
$.01 par value, held by non-affiliates of the registrant as of March 18, 1997
was approximately $24,200,000. Determination of stock ownership by
non-affiliates was made solely for the purpose of responding to this requirement
and registrant is not bound by this determination for any other purpose.
DOCUMENTS INCORPORATED BY REFERENCE
Part III incorporates information by reference from portions of the
registrant's Proxy Statement to be filed with respect to the 1997 Annual Meeting
of Stockholders scheduled to be held on June 12, 1997.
<PAGE> 3
APOGEE, INC.
FORM 10-K - FISCAL YEAR ENDED DECEMBER 31, 1996
CONTENTS AND CROSS REFERENCE SHEET
FURNISHED PURSUANT TO GENERAL INSTRUCTION G(4) OF FORM 10-K
<TABLE>
<CAPTION>
Form 10-K Form 10-K Form 10-K
Part No. Item No. Description Page No.
-------- -------- ----------- --------
<S> <C> <C> <C>
I 1 Business............................................ 1
General.......................................... 1
Outpatient Behavioral Healthcare Market ......... 1
Business Strategy................................ 2
Patient Services................................. 5
Sales and Marketing.............................. 6
Reimbursement.................................... 6
Competition...................................... 8
Regulation....................................... 9
Employees........................................ 10
Insurance........................................ 10
Executive Officers of the Company................ 11
2 Properties.......................................... 12
3 Legal Proceedings................................... 13
4 Submission of Matters to a Vote of Security Holders. 13
II 5 Market for Registrant's Common Equity and Related
Stockholder Matters.............................. 14
6 Selected Financial Data............................. 14
7 Management's Discussion and Analysis of Financial
Condition and Results of Operations.............. 15
8 Financial Statements and Supplementary Data......... 21
9 Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure.............. 37
III 10 Directors and Executive Officers of the Registrant.. 37
11 Executive Compensation.............................. 37
12 Security Ownership of Certain Beneficial Owners and
Management....................................... 37
13 Certain Relationships and Related Transactions...... 38
IV 14 Exhibits, Financial Statement Schedules and Reports
on Form 8-K...................................... 38
Signatures.............................................................. 39
</TABLE>
<PAGE> 4
PART I
ITEM 1. BUSINESS.
GENERAL
Apogee, Inc. ("Apogee" or the "Company") is one of the
largest multi-disciplinary providers of outpatient behavioral health services in
the United States. The Company provides behavioral health and related services,
principally at free-standing clinics and currently operates 115 behavioral
health clinics located in 13 states and the District of Columbia. The Company
offers full and shared risk arrangements to employers and managed care
organizations to perform behavioral health services on a capitated,
sub-capitated and case rate basis. In addition, Apogee provides an array of
other behavioral health services including: employee assistance programs; third
party clinical case management and claims adjudication; and management and
staffing for acute and subacute inpatient facilities, correctional institutions
and skilled nursing facilities through contractual agreements.
Apogee's outpatient practices provide a broad range of
behavioral health services, including diagnosis, psychiatric consultation,
psychological assessment and evaluation, medication monitoring, group and
individual psychotherapy, behavioral management, marriage, family and child
therapy and substance abuse and chemical dependency rehabilitation. The
Company's multi- disciplinary practices typically employ some or all of the
following professionals: board certified or board eligible psychiatrists;
licensed clinical psychologists; licensed clinical social workers; registered
psychiatric nurse practitioners; licensed marriage, family and child counselors;
and other allied mental health professionals.
The Company has announced the termination of its
long-term care operations and, in certain markets, consolidation of a number of
outpatient group practices. The Company anticipates that such restructuring will
be substantially complete by June 1997. See "Business Strategy - Plan for
Growth" below, "Item 7. Management's Discussion and Analysis of Financial
Condition and Results of Operations" and Note 10 to Notes to Consolidated
Financial Statements contained in Part II, Item 8 of this Report.
OUTPATIENT BEHAVIORAL HEALTH CARE MARKET
Mental illness is a serious health problem in the United
States. In 1990, $43 billion was spent on behavioral health care services and
the cost of lost productivity due to mental illnesses was approximately $75
billion, according to a study by the University of California, San Francisco,
Institute for Health and Aging. Based on this study, the market for outpatient
behavioral health services in the United States was approximately $10 billion in
1990 and grew at a compound annual rate of approximately 12% between 1985 and
1990. The Company believes that this growth has resulted from (i) overall
increases in demand for behavioral health care services and (ii) increased
utilization of outpatient behavioral health care services at the expense of
higher cost inpatient
1
<PAGE> 5
providers. The Company is not aware of any comprehensive study more recent than
the University of California study which specifically quantifies the outpatient
behavioral health market. Management believes that while this continues to be a
growing market, the growth rate has abated due to increased managed care of
behavioral healthcare.
BUSINESS STRATEGY
Value Based Business
Apogee's management has formally adopted the Company's
Mission and Values -- the reason Apogee is in business, and the standards for
which its employees should strive on a daily basis. This Mission and these
Values have been introduced to its employees and, when fully integrated into the
Company's culture, will distinguish Apogee from its competitors.
MISSION: To help our patients achieve their highest level of
functioning through quality, ethical and cost-effective
behavioral healthcare.
VALUES
PATIENTS COME FIRST: ....patient care is the most important thing
we do.
RESPECT FOR THE INDIVIDUAL: ....the handshake between the Company
and each employee.
EXCEEDING CUSTOMER EXPECTATIONS: ....the needs of our customers
define our services.
UNCOMPROMISING INTEGRITY: ....compels us to always do the right
thing.
CONTINUOUS SELF-RENEWAL: ....commitment to setting the standard of
excellence which unifies and
strengthens us.
It is management's belief that a strong commitment to
these values will enable the Company's employees to build the Company's business
and their careers and provides the foundation upon which Apogee's business plans
are developed.
Plan for Growth
Since its inception in 1991, the Company has experienced
significant growth in net revenues due largely to acquisitions. During 1996,
management curtailed its acquisition activity in order to evaluate the Company's
operations in light of continuing regulatory and market changes. As a result,
the Company determined to effect a restructuring. After the restructuring, the
Company will have essentially discontinued services provided in long term care
facilities which is a fundamental change in the Company's strategy. Long-term
care services represented 44%, 22% and 13% of the Company's net revenue during
1994, 1995 and 1996, respectively. While management has taken proactive steps to
de-emphasize this sector during the last several years, long term care was still
a substantial portion of the Company's business in 1996. The Company's decision
2
<PAGE> 6
to discontinue services to long-term care facilities was based on the current
operating environment, including the cumulative effect of actions taken by
Medicare intermediaries in certain states, and the overall outlook for this
market in the future.
As a result of the discontinuation of the long term care
operations, the Company is able to significantly reduce corporate overhead costs
and will be able to focus full management attention on the outpatient and
contract service areas. In addition, by eliminating and consolidating
underperforming clinic locations, the Company believes it has positioned itself
to build for future success.
The Company's plan for growth has three principal
components: (i) increase managed care business; (ii) develop regional and local
market contract service opportunities; and (iii) explore strategic alliances
both nationally and within specific geographic markets.
Increase managed care business. Apogee plans to continue
to partner with managed care organizations ("MCOs"). The Company's current group
practice operations are leaders in their geographic markets and, therefore,
should be attractive to MCOs. In the majority of the markets the Company
services, managed care continues to gain market share and appears to be growing
at a rate substantially faster than its competition. MCOs are generally
interested in quality of care, geographic coverage, provider network
convenience, treatment outcomes and price. In Apogee's experience, low cost is
often a determining factor when contracting with MCOs, therefore it is essential
for the Company to focus on cost containment in preparation of increased managed
care business. Apogee intends to work with MCOs to continue enrolling Apogee
clinicians on the MCOs' panels, expanding services currently provided and
securing additional capitated and case rate contracts.
Apogee believes there also will be an opportunity for
partnering with MCOs due to the increasing number of Medicare and Medicaid lives
being covered by MCOs within certain of the states in which Apogee is currently
operating. Apogee has already partnered with several MCOs to develop the
behavioral health provider panels and operating protocol in preparation for the
MCOs application process with state health agencies. Through this process, the
Company has gained an additional 40,000 Medicare/Medicaid covered lives and
anticipates servicing significantly more lives in the second half of 1997.
Develop regional and local market contract service
opportunities. Management believes there is significant opportunity to continue
expanding services provided through contractual arrangements. The Company
currently provides employee assistance programs, third party clinical case
management and claims adjudication for behavioral health claims, management and
staffing of acute and sub-acute inpatient facilities and correctional
institutions through contractual agreements. Revenues from contractual
arrangements have continued to increase as a percentage of the Company's net
revenues accounting for 13%, 22% and 29% of net revenues in 1994, 1995 and
1996, respectively. The Company believes profit margins on these contractual
arrangements
3
<PAGE> 7
are higher than those for traditional fee-for-service business, due largely to
the value added aspect of these arrangements. Apogee intends to support growth
in this area through an investment in dedicated regional and local market
business development personnel.
The Company's Integra division is also a central element
of the Company's plan for growth in managed care and contract services. Integra
specializes in behavioral health contracting for employee assistance programs,
third party clinical case management and claims adjudication and capitated
arrangements with MCOs and directly with employers. Integra has experienced
rapid growth with revenues increasing from an annualized run rate of $3.5
million in 1994 to $9.5 million in January of 1997. Apogee believes this growth
is attributable to Integra's focus on quality of care, customer service and
satisfaction and utilization of outcome based measurements. Integra has
experienced increasing demand for third party clinical case management services
for behavioral health claims, and has increased covered lives using this service
from approximately 35,000 in 1994 to 160,000 at the beginning of 1997, an
increase of over 350%. Customers of this service are primarily large
corporations with self-funded employee health insurance programs. Management
believes this success is largely due to the Company's ability to clearly
demonstrate both reduced costs to employers and improved quality of care to
employees.
Explore strategic alliances both nationally and within
specific geographic markets. Healthcare is experiencing an unprecedented era of
consolidation and strategic alliances and behavioral health is no exception. The
Company believes it will be important to develop strategic alliances to prepare
for future growth. Due to the differences in individual markets, as well as the
difference in the nature of Apogee's operations in each market, the Company's
targeted partners will vary by market. Management believes that acute care
hospitals, psychiatric hospitals, HMOs, MCOs, physician groups, independent
provider associations ("IPAs") and managed service organizations are examples of
potential partners with which the Company can enter into strategic alliances.
One of the likely vehicles for strategic alliances will
be affiliating with integrated delivery systems ("IDS"). IDS's are a vertical
integration of healthcare providers, physicians and payors who mutually benefit
by networking to: (i) control the quality of patient care; (ii) leverage
administrative costs and reduce capital costs; and (iii) increase patient access
to service. Membership in an IDS is generally on the basis of a contractual or
shared ownership agreement. Apogee plans to explore IDS arrangements in targeted
geographic markets in which the Company has an existing network of outpatient
services sites with sufficient presence to engage an IDS affiliation.
In 1996, Apogee completed its first IDS in Jacksonville,
Florida, with a large acute care hospital chain. Under the terms of this joint
venture, the parties will collectively secure and service full and partial risk
contracts for behavioral health services. Under the terms of the agreement,
Apogee provides management services to the joint venture for establishing and
maintaining provider networks, developing clinical protocols, utilization review
and case management, as well as administrative functions.
4
<PAGE> 8
Cost Containment
A central aspect of the Company's strategy is to
position itself as a low-cost provider of behavioral health services. During the
last two years, Apogee made significant progress in the transition of its
clinical compensation model from a fixed cost model to a variable cost model and
anticipates that this process will be substantially completed in 1997. In
addition to improving productivity, this transition will help reduce the
seasonal fluctuation the Company has experienced previously.
During the last two years, the Company has also
reorganized its regional and corporate administrative functions to both reduce
costs and better support the needs of the clinical operations. Management
believes there is additional opportunity to continue reducing costs through
improved standardization of the clinical and administrative disciplines and
systems. Through continued enhancement of the clinical and administrative
systems, the Company will be better able to operate successfully in an
increasingly challenging reimbursement environment.
PATIENT SERVICES
The following table identifies the current locations of the
Company's outpatient clinics as of December 31, 1996, after adjusting for the
impact of restructured locations.
<TABLE>
<CAPTION>
Location No.
-------- ---
<S> <C>
Florida ....................... 28
California .................... 18
Wisconsin ..................... 15
Virginia ...................... 14
Maryland ...................... 13
Pennsylvania .................. 6
New Jersey .................... 5
New York ...................... 5
Illinois ...................... 3
Nevada ........................ 3
Arizona ....................... 2
Rhode Island .................. 1
Washington .................... 1
District of Columbia .......... 1
---
Total ............. 115
===
</TABLE>
The Company's philosophy of care is to provide services
in the least restrictive but most appropriate setting to achieve the desired
patient outcome. A wide range of outpatient services are offered, including
diagnostic evaluation, individual and group psychotherapy for adults,
adolescents and children, marriage and family therapy, diagnostic psychological
testing and psychiatric consultation and evaluation and follow-up treatment for
those requiring medication. The
5
<PAGE> 9
Company's services are designed to provide patients with access to treatment at
all levels of care. The desired outcome of all behavioral health services
provided by Company clinicians is to return the patient to his or her optimal
functional capacity utilizing the most cost-effective services and settings.
The Company's professionals treat patients with a wide
variety of behavioral, psychological and psychiatric problems. The most common
problems treated by behavioral health professionals are depressive disorders,
anxiety disorders (such as panic attacks or phobias), bipolar disorders (such as
manic depressive conditions), psychoses (such as schizophrenia or hallucinatory
conditions), general personality problems, alcohol and chemical dependency
problems and child, family and marital problems. The conditions treated by the
Company's professionals can, in many cases, seriously interfere with a patient's
ability to function occupationally, socially and interpersonally. Such loss of
function can result in reduced productivity, impaired job performance and, in
some instances, total disability.
SALES AND MARKETING
Outpatient Clinics. In the outpatient area, marketing
efforts focus on increasing the number of patients referred to the Company by
managed care companies, primary care physicians, other behavioral health care
providers and employers. Increased referrals are generated by providing
information to managed care case workers and physicians on the Company's
services, establishing contracts with managed care companies and employers and
by participating in local health associations. These activities are performed by
marketing representatives as well as operations management.
Managed Care Payors. The Company's marketing to
insurance and managed care companies, which is primarily conducted by local and
regional management personnel, emphasizes the Company's ability to provide a
wide array of cost-effective services to individuals at convenient locations
within a geographic region. The Company believes that in geographic areas where
it has multiple clinic operations it has a competitive advantage in marketing to
managed care payors. In addition, the Company also believes its ability to offer
payors a variety of reimbursement arrangements such as capitation,
sub-capitation and case rates, sets it apart from many of its competitors. By
contracting with the Company, insurance and managed care companies are able to
minimize the number of providers with which they contract.
Contract Services. The Company believes there is
significant opportunity to continue expanding services provided through
contractual arrangements. Apogee intends to support growth in this area through
increased employment of dedicated regional and local market business development
personnel.
REIMBURSEMENT
The Company provides it services through group practices
where revenues are principally derived from third party payors.
6
<PAGE> 10
The Company estimates that 87% of its net revenues
during fiscal 1996 were derived from group practices (which includes services
provided at outpatient clinics and under contracts with managed care companies,
inpatient acute care facilities and other payors) and 13% were derived from
long-term care services. Following its withdrawal from the long term care
sector, the Company anticipates that revenues from the Medicare program will be
less than 5% of net revenues. The following table sets forth the Company's
principal sources of reimbursement as a percentage of net revenues:
<TABLE>
<CAPTION>
Year Ended December 31,
---------------------------
Payor Source 1996 1995 1994
------------ ---- ---- ----
<S> <C> <C> <C>
Managed Care and Other Third
Party Payors ............ 59% 50% 38%
Self Pay ................... 20 22 17
Medicare ................... 16 21 37
CHAMPUS .................... 3 4 3
Medicaid ................... 2 3 5
--- --- ---
100% 100% 100%
=== === ===
</TABLE>
Managed Care and Other Third Party Payors. The Company
receives reimbursement in mainly two forms: i) fee for service arrangements, and
ii) capitated contracts.
i) Fee for Service. For managed care services, the
Company enters into an agreement with a managed care payor for a stated fee per
service and agrees to clinician credentialing as well as preauthorization
requirements. For other third party payors, the Company bills and accepts the
payors' reasonable and customary payment and pursues the balance of the service
fee directly from the patient.
ii) Capitated Contracts. The Company intends to enter
into contracts to accept the risk for a continuum of behavioral health care
services in regions where the Company has achieved significant market
penetration. Under a capitated contract, the Company agrees to provide
behavioral health care services to members of a group at a fixed rate per
member, regardless of the services actually performed. Apogee's contracts to
provide behavioral health services on a capitated basis covered approximately
875,000 and 780,000 lives at January 1, 1997 and 1996, respectively. In
addition, the Company covered approximately 160,000 and 70,000 lives for
clinical case management services at January 1, 1997 and 1996, respectively;
which are also reimbursed on a capitated basis, although Apogee is not at risk
for the actual claims incurred.
Medicare. Medicare is a federal health insurance program
which provides health insurance coverage for certain disabled persons, for
persons aged 65 or older and for certain persons with end stage renal disease.
There are two insurance plans in the Medicare program: Part A which covers
inpatient services, home health care and hospice care and Part B which covers
physicians, other health care professionals and outpatient services. Medicare is
funded by both beneficiary and federal contributions. When behavioral health
care services are provided to patients in long-term care facilities by health
care professionals, such as psychiatrists, clinical psychologists and social
workers, Medicare Part B payments are based on the applicable Resource Based
Relative Value
7
<PAGE> 11
Scale ("RBRVS") Fee Schedule which differs by geographic region. Medicare
beneficiaries are required to pay a deductible and copayment for most Part B
services that generally equals 20% of the Medicare allowed amount. However, for
therapeutic treatment of mental, psychoneurotic and personality disorders,
Medicare pays 62-1/2% of the approved amount minus the 20% coinsurance, thus
requiring the beneficiary to pay about 50% of the approved Medicare allowable
fee. This limitation does not apply to diagnostic services.
Medicaid. Medicaid is the state administered and state
and federally funded program which provides health insurance coverage for
certain low income individuals. For qualified Medicare beneficiaries, the
Medicaid program pays the beneficiary's Part B premiums and may reimburse all
deductibles and co-payment portions of the approved Medicare charge up to an
allowable amount established by each Medicaid program. The extent of actual
co-payment contributions varies widely by state. Most Medicaid programs cover
behavioral health care services but may limit the number of approved visits per
year. There has been an increasing trend for Medicaid programs to contract with
managed care organizations to administer care and control costs for its
beneficiaries. In these situations, the Company and its providers must be
approved to participate on the select provider panel in order to treat patients.
Government and other third-party payors' health care
policies and programs have been subject to changes in payment levels and payment
methodologies during past years, including determination of medical necessity
for behavioral health services. There can be no assurance that future changes
will not reduce reimbursement from these sources for behavioral health care
services.
COMPETITION
The health care industry in general and the behavioral
health services industry in particular are highly fragmented and very
competitive on a local basis. However, the Company believes, based upon its
analysis of potential acquisition candidates, that it is one of the largest
independent providers of outpatient behavioral health and related services on a
national basis. As the health care system in the United States continues to
change, the Company believes that strong multi-regional or national providers
with comprehensive, high quality programs and effective utilization and
administrative procedures in place will be the providers of choice for the
growing managed care systems. The primary competitive factors in the behavioral
health care services market are quality of care, cost effectiveness, treatment
outcomes and the ability to meet the needs of referral and payor sources.
The Company's primary competitors in most markets are
local outpatient behavioral health providers. On a regional and national basis,
the competition for outpatient behavioral health services also comes from
behavioral health preferred provider organizations -- networks of individually
owned clinics contracting with the payor source to provide services to those
members that select them from a published panel of providers. In addition, some
providers of inpatient behavioral health care, which may have greater resources
than the Company, are developing networks of outpatient clinics generally in the
areas of their inpatient facilities.
8
<PAGE> 12
REGULATION
Licensing and Certification. Psychiatrists, clinical
psychologists, clinical social workers and registered psychiatric nurse
specialists must be licensed in the state in which they practice. Such licensure
is controlled by state boards as well as the regulatory authorities in each
state. The Company has procedures designed to ensure that each of its
professionals employed is properly licensed and has satisfied his or her
continuing education requirements. In addition, certain states in which the
Company operates impose licensure or certification requirements on the Company's
facilities or operations.
The Company anticipates that each of its facilities and
practitioners will be able to maintain applicable licenses, certifications and
accreditation and obtain reasonable reimbursement for services. However, the
loss, denial or restriction of any such reimbursement, licensure, accreditation
or certification, including certification-of-need or exemption through changes
in applicable regulatory requirements, an enforcement action or otherwise, could
have a material adverse effect on the Company.
Governmental Health Care Regulation. As a behavioral
health care provider, the Company is currently subject to extensive and
frequently changing federal, state and local regulations governing licensure,
conduct of operations at existing facilities, purchase or lease of existing
businesses, cost containment and direct employment of licensed professionals by
business corporations. The various types of regulatory activity affect the
Company's business either by controlling its growth, restricting licensure of
the business entity or by controlling the reimbursement for services provided.
In order to receive Medicare reimbursement, the
Company's local operations must be registered with Medicare as a group provider.
In addition, each individual provider must be certified as an independently
practicing provider and be assigned an individual provider number. The
certification criteria, which are established by the Department of Health and
Human Services, are interpreted and administered by each state.
Medicaid programs do not generally require certification
of the Company or its providers over and above the requirements of Medicare.
The Social Security Act imposes criminal penalties upon
persons who make or receive kickbacks, bribes or rebates in connection with the
Medicare or Medicaid programs. The anti-fraud and abuse rule prohibit providers
and others from soliciting, offering, receiving or paying, directly or
indirectly, any remuneration in return for either making a referral for a
Medicare or Medicaid-covered service or item or ordering any covered service or
item. In addition, the Medicare and Medicaid Patient and Program Protection Act
of 1987 imposed civil sanctions for violation of these prohibitions, punishable
by exclusion from the Medicare and Medicaid programs; such exclusion, if applied
to the Company's operations, could result in significant loss of reimbursement.
In order to provide guidance with respect to the anti-fraud and abuse rules, the
Office of the
9
<PAGE> 13
Inspector General ("OIG") issued final regulations outlining certain "safe
harbor" practices, which although potentially capable of inducing prohibited
referrals, would not be prohibited if all applicable requirements are met. A
relationship which fails to satisfy a safe harbor is not necessarily illegal,
but could be scrutinized under a case-by-case analysis. In February 1997, the
OIG issued an interim rule regarding its recently mandated proposals for
accepting and issuing advisory opinions on the anti-fraud and abuse rules.
Because the anti-fraud and abuse laws have been broadly interpreted, they limit
the manner in which the Company can acquire businesses and market its services
to, and contract for services with, physicians, nursing homes and other health
care providers. Management considers and seeks to comply with these regulations
in planning and conducting its activities, and believes that its activities do
not violate the anti-fraud and abuse statute.
Federal and some state laws impose restrictions on
physicians', and, in a few states, on psychologists' and other behavioral health
care professionals' referrals for certain designated health services to entities
with which they have financial relationships. The Company believes its
operations are structured to comply with these restrictions to the extent
applicable. There can be no assurance that the federal government or other
states in which the Company operates will not enact similar or more restrictive
legislation or restrictions that could under certain circumstances impact the
Company's operations.
In certain states, the employment of psychiatrists,
psychologists and other behavioral health care professionals by business
corporations is a permissible practice. However, many states, including some
states in which the Company operates, have interpreted existing medical practice
licensing laws to restrict business corporations, such as the Company, from
providing behavioral health services through the direct employment of
psychiatrists and, in a few states, psychologists and other behavioral health
care professionals. The Company believes its operations are structured, or can
be restructured, if necessary, to comply with applicable laws and regulations.
However, there can be no assurance that other states in which the Company
operates will not enact similar or more restrictive legislation or regulations.
EMPLOYEES
At December 31, 1996, the Company employed approximately
1,000 full time equivalent employees. The Company has not experienced any
significant difficulty in filling open positions with qualified clinicians. None
of the Company's employees is represented by a labor union and the Company is
not aware of any current activities to organize any of its employees. Management
considers the relationship between the Company and its employees to be good.
INSURANCE
The Company believes that it maintains the types and
amounts of insurance customary in the behavioral health services industry,
including coverage for general liability, property damage, workers' compensation
malpractice liability, workplace misconduct and employment related practices.
The Company considers its insurance coverage to be adequate both as to risks and
amounts.
10
<PAGE> 14
EXECUTIVE OFFICERS OF THE COMPANY
Certain information with respect to the executive officers of the
Company is set forth below:
<TABLE>
<CAPTION>
Age at
December 31,
Name Position with the Company 1996
- -------------------------------------------------- ------------------------- ------------
<S> <C> <C>
John H. Foster ................................... Chairman of the Board, Chief
Executive Officer and Director 54
Lawrence M. Davies ............................... President, Chief Operating Officer
and Director 38
Alan N. Vinick ................................. Senior Vice President, Finance and
Chief Financial Officer 53
Massoud G. Hampton, Ph.D. ........................ Vice President of Clinical Services 46
Jane P. Stanton................................... Vice President of Human Relations 43
Stanley F. Szczygiel.............................. Vice President of Finance and
Secretary 44
</TABLE>
JOHN H. FOSTER has been Chairman of the Board and Chief
Executive Officer of the Company since March 1991. Mr. Foster has been Chairman
of the Board and Chief Executive Officer of NovaCare, Inc., a leading national
provider of comprehensive medical rehabilitation services ("NovaCare"), since
December 1984. Mr. Foster is a director of Corning Incorporated, an
international corporation with business interests in specialty materials and
communications. Mr. Foster is the founder and Chairman of the Board of Foster
Management Company, an investment advisor, and general partner of various
venture capital investment funds.
LAWRENCE M. DAVIES has been a director of the Company
since January 1992 and its President since June 1993. Mr. Davies was Vice
President of the Central Division of the Contract Services Group of NovaCare
from June 1992 to May 1993 and Division Vice President of the Midwest Region of
the Contract Services Group of NovaCare from September 1988 to May 1992. From
January 1987 to August 1988, Mr. Davies was Director of Corporate Development
for NovaCare. Mr. Davies was Manager of Mergers and Acquisitions for Foster
Medical Corporation from August 1984 to December 1986.
ALAN N. VINICK has been Senior Vice President, Finance
and Chief Financial Officer of the Company since January 1996. From February
1994 to December 1995, Mr. Vinick was Senior Vice President of the Outpatient
Division of NovaCare. Mr. Vinick was Senior Vice President, Finance and
Administration, Treasurer and Chief Financial Officer of RehabClinics, Inc., a
provider of outpatient physical therapy services, from February 1992 to February
1994. From January 1990 to February 1992, he was Vice President and Chief
Financial Officer of Orthopedic Services, Inc., a provider of orthotic and
prosthetic rehabilitation services ("OSI"). From July 1988 to March 1990, he was
Vice President and Chief Financial Officer of Heritage Health Systems, Inc.,
which owned and managed health maintenance organizations and was privately held
and financed by Foster Management Company. From January 1990 to March 1990, Mr.
Vinick was
11
<PAGE> 15
employed by both OSI and Heritage Health Systems, Inc. From December 1984 to
June 1988, he served as Vice President and Chief Financial Officer of John
Hancock HealthPlans, Inc.
MASSOUD G. HAMPTON, Ph.D. has been Vice President of
Clinical Services for the Company since February 1994. Dr. Hampton was the
founder and Director of the Institute of Aging at St. Vincent Hospital and
Health Care Centers from December 1985 to January 1994. Dr. Hampton is a
licensed clinical psychologist and holds a Ph.D. in Life Span Developing and
Aging from Indiana University and an M.S. in Developmental Psychology from
Indiana State University. Dr. Hampton has also completed a post doctoral
fellowship in geriatric psychology at the University of Notre Dame. Dr. Hampton
has served as Chairman of the Governor of Indiana's Task Force on Alzheimer's
Disease, as President of the Advisory Council for the Central Indiana Council on
Aging and as a delegate to the White House Conference on Aging. In 1993, Dr.
Hampton received the Indiana Public Health Foundation Award for Gerontology.
From 1987 to 1993, Dr. Hampton was an adjunct professor of psychology at Indiana
University.
JANE P. STANTON has been Vice President of Human
Resources for the Company since July 1993. Ms. Stanton served as the Manager of
Human Resources for the Central Division of the Contract Services Group of
NovaCare from June 1992 to June 1993 and from April 1991 to May 1992, served as
the Manager of Human Resources for the Midwest Division of the Contract Services
Group of NovaCare. For over 12 years Ms. Stanton held positions of increasing
responsibility in the human resource area of Dayton-Hudson Corporation,
including from April 1988 to September 1990, as the Group Human Resources
Manager for the Hudson Department Stores and from April 1987 to April 1988, as
the Group Human Resources Manager for the Dayton Department Stores.
STANLEY F. SZCZYGIEL has been Vice President of Finance
and Secretary of the Company since October 1993. From January 1993 to October
1993, Mr. Szczygiel managed Acquisition Management Services, Inc., a mergers and
acquisition consulting company. From 1986 to 1992, Mr. Szczygiel was with Abbey
Home Healthcare which acquired Foster Medical Corporation in 1989. Mr. Szczygiel
was the Vice President of Finance from 1987 to 1992 and Corporate Controller
from 1986 to 1987 of Abbey Home Healthcare. From 1973 to 1985, Mr. Szczygiel
held various financial management positions at Exxon Corporation, Memorex
Corporation and Coopers & Lybrand.
No family relationship exists between any of the
directors or executive officers of the Company. Executive officers serve at the
discretion of the Board of Directors.
ITEM 2. PROPERTIES.
The Company's principal executive officers are located
at 1018 West Ninth Avenue, King of Prussia, Pennsylvania. In addition, the
Company leases other office space and clinical facilities in various locations
across the United States. See Note 10 of Notes to the Company's Consolidated
Financial Statements for information concerning the Company's leases for its
office and patient care facilities. The Company does not anticipate that it will
experience any difficulty
12
<PAGE> 16
in renewing any such leases upon their expiration or obtaining different space
on comparable terms if such leases are not renewed. The Company believes that
these facilities are well maintained and are of adequate size for present needs
and planned expansion in the near future.
ITEM 3. LEGAL PROCEEDINGS
From time to time, the Company is a party to certain
claims, suits and complaints which arise in the ordinary course of business.
Currently, there are no such ordinary course claims, suits or complaints which,
in the opinion of management, would have a material adverse effect on the
Company's financial position, results of operations or liquidity. In addition,
as further described in Note 10 to the Company's Consolidated Financial
Statements contained in Part II, Item 8 of this Report, certain of the Company's
Medicare Part B and related co-insurance billings are under review by the Office
of Inspector General of the Department of Health and Human Resources and the
Department of Justice.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
Not applicable.
13
<PAGE> 17
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS.
Apogee's common stock trades on the NASDAQ National
Market Tier of the NASDAQ Stock Market(SM) under the symbol APGG. On March 18,
1997, there were approximately 122 holders of record and over 1,000 beneficial
holders of the Common Stock.
The following table sets forth the range of high and low
closing prices per share of Common Stock since January 1, 1995, as reported on
The NASDAQ Stock Market(SM):
<TABLE>
<CAPTION>
Common Stock Prices
High Low
---- ---
<S> <C> <C>
Year Ended December 31, 1996:
First Quarter $10.75 $ 3.50
Second Quarter 8.25 5.38
Third Quarter 7.00 5.25
Fourth Quarter 6.94 3.13
Year Ended December 31, 1995:
First Quarter $22.75 $16.25
Second Quarter 19.25 14.75
Third Quarter 19.50 17.00
Fourth Quarter 17.75 7.63
</TABLE>
Over the past two years, the Company's common stock
price has been subject to significant volatility. Due to the nature of Apogee's
business and stock market forces beyond the Company's control, such changes in
the Company's stock price can be sudden.
No dividends have been declared on the common stock
since the Company's inception. The Company does not expect to declare any cash
dividends in the foreseeable future.
ITEM 6. SELECTED FINANCIAL DATA
The following selected financial data should be read in
conjunction with the Company's consolidated financial statements and the
accompanying notes presented elsewhere herein.
14
<PAGE> 18
APOGEE, INC.
FIVE-YEAR FINANCIAL SUMMARY
(DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<TABLE>
<CAPTION>
Years Ended December 31,
-----------------------------------------------------------------------------
1996 1995 1994 1993 1992
---- ---- ---- ---- ----
<S> <C> <C> <C> <C> <C>
STATEMENT OF OPERATIONS DATA:
Net revenues ....................... $ 78,727 $ 68,269 $ 33,473 $ 6,626 $ 1,651
Gross profit (loss) ................ 17,325 16,774 7,762 403 (411)
Adjusted EBITDA(1) ................. 4,583 5,230 1,175 (2,290) (1,170)
(Loss) income from operations ...... (12,826) (2,924) 149 (2,445) (1,240)
Net (loss) income(2) ............... (13,594) (2,451) 387 (2,831) (1,372)
Net (loss) income per common share . (1.37) (0.26) 0.06 (0.68) (0.33)
Shares used in net (loss) income per
common share computation ......... 9,887,362 9,497,279 6,883,215 4,154,864 4,154,864
</TABLE>
<TABLE>
<CAPTION>
As of December 31,
-----------------------------------------------------------------------------
1996 1995 1994 1993 1992
---- ---- ---- ---- ----
<S> <C> <C> <C> <C> <C>
BALANCE SHEET DATA:
Current assets ............... $16,445 $ 29,886 $42,179 $ 2,653 $ 826
Total assets ................. 97,783 109,051 95,123 9,061 2,949
Current liabilities .......... 23,547 23,305 12,990 2,536 1,419
Total debt ................... 12,808 11,246 10,040 9,880 3,794
Stockholders' equity (deficit) 65,181 78,739 74,561 (4,427) (1,620)
</TABLE>
(1) Adjusted EBITDA represents earnings before interest, income taxes,
depreciation, amortization of intangible assets and excess of cost over fair
value of net assets acquired and restructuring and related non-recurring
charges.
(2) Net loss includes provision for restructuring and related non-recurring
charges of $14,100 and $5,600 in 1996 and 1995, respectively.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
The Company provides behavioral health care and related
services, principally at free- standing clinics. The Company commenced
operations on March 15, 1991. During 1996, 1995, and 1994, the Company acquired
6, 19, and 14 businesses, respectively. The Company operates 115 outpatient
behavioral health clinics located in 13 states and the District of Columbia.
15
<PAGE> 19
Results of Operations
The following table sets forth, for the periods
indicated, the relative percentages which certain items in Apogee's Consolidated
Statements of Operations bear to net revenues:
<TABLE>
<CAPTION>
Years Ended December 31,
---------------------------------
1996 1995 1994
----- ----- -----
<S> <C> <C> <C>
Net revenues ......................................... 100.0% 100.0% 100.0%
Gross profit ......................................... 22.0% 24.6% 23.2%
Selling and administrative expenses .................. 12.5% 13.0% 15.5%
Provision for doubtful accounts ...................... 5.0% 5.0% 5.3%
Amortization of intangible assets and excess cost over
fair value of net assets acquired ................. 2.9% 2.7% 1.9%
Restructuring and related non-recurring charges ...... 17.9% 8.2% ---
----- ----- -----
(Loss) income from operations ........................ (16.3)% (4.3)% .5%
Interest expense (includes other expenses) ........... 1.0% .8% 2.0%
Interest (income) .................................... (.2)% (1.6)% (2.9)%
----- ----- -----
(Loss) income before income taxes .................... (17.1)% (3.5)% 1.4%
Provision for income taxes ........................... .2% .1% .2%
----- ----- -----
Net (loss) income .................................... (17.3)% (3.6)% 1.2%
===== ===== =====
</TABLE>
Net Revenues
Net revenues for 1996 increased 15% to $78,727 from
$68,269 in 1995. This increase is a result of acquisitions made during 1995 and
1996. After adjusting for the impact of closing certain long term care
operations as a result of the Company's 1995 restructuring, base business
revenues decreased approximately $2,700, primarily as a result of: 1) reduced
revenue volume in certain long term care markets where the Company continued to
provide service during 1996, but was not actively replacing terminated direct
care providers; and 2) the loss of several group practice contracts in late
1995, partially offset by increased volumes from other payors/patients.
Net revenues for 1995 increased to $68,269 from $33,473
in 1994, an increase in revenues of $34,796 or 104% over 1995. Approximately 94%
of this increase in revenues was attributable to acquisitions made in 1995 and
the full year impact of acquisitions made in 1994. Base business growth
accounted for approximately $2,200 of the increase in net revenues, principally
a result of increased volume.
16
<PAGE> 20
Gross Profit
Gross profit comprises net revenues less personnel,
field management, facility and other costs and expenses directly associated with
the delivery of services. Gross profit increased to $17,325 in 1996 from $16,774
in 1995. This increase is due to acquisitions made during 1995 and 1996. After
adjusting for the impact of closing certain long term care operations as a
result of the Company's 1995 restructuring, gross profit from base business
decreased approximately $2,400, primarily as a result of: 1) the loss of several
group practice contracts in late 1995; 2) clinician turnover/productivity at
certain group practice operations; and 3) investment in clinical and field
support positions.
Gross profit increased 116% to $16,774 in 1995 from
$7,762 in 1994. This increase was attributable to acquisitions made in 1994.
Gross profit from base business is essentially consistent with the prior year,
primarily due to a marginal increase in group practices offset by a decrease in
long-term care gross profit. The decrease in long-term care was primarily a
result of higher field management costs as a percentage of revenue.
Selling and Administrative Expenses
Selling and administrative expenses comprise corporate
office, regional and local management, centralized billing and marketing
expenses and increased to $9,864 in 1996 from $8,876 in 1995. This increase is a
result of continued investment in infrastructure and selling and administrative
expenses from the businesses acquired in 1995 and 1996. Selling and
administrative expenses as a percentage of net revenues decreased to 12.5% for
1996 from 13.0% in 1995, due primarily to improved leveraging of the corporate
and regional overhead costs.
Selling and administrative expenses increased to $8,876
in 1995 from $5,181 in 1994. This increase is a result of investment in
corporate infrastructure and selling and administrative expenses from the
businesses acquired in 1995. Selling and administrative expenses as a percentage
of net revenues decreased to 13.0% for 1995 from 15.5% in 1994, due primarily to
improved leveraging of the corporate overhead costs.
Provision for Doubtful Accounts
The provision for doubtful accounts increased to $3,886
in 1996 from $3,408 in 1995. This increase is attributable to higher net
revenues as the provision for doubtful accounts remained consistent at 5% of net
revenues for both years. The provision for doubtful accounts is estimated based
on an ongoing review of collectibility of the Company's accounts receivable. The
provision for doubtful accounts increased to $3,408 in 1995 from $1,784 in 1994
as a result of the increase in net revenues.
Amortization of Intangible Assets and Excess Cost Over Fair Value of Net Assets
Acquired
Amortization of intangible assets and excess cost over
fair value of net assets acquired increased to $2,301 in 1996 from $1,814 in
1995. This increase was due to additional businesses
17
<PAGE> 21
acquired in 1996 and the full year of amortization for businesses acquired in
1995.
Amortization of intangible assets and excess cost over
fair value of net assets acquired increased to $1,814 in 1995 from $648 in 1994.
This increase was due to additional businesses acquired in 1995 and the full
year of amortization for businesses acquired in 1994.
Restructuring and Related Non-recurring Charges
As discussed in Notes 8 and 9 to the accompanying
Consolidated Financial Statements, in 1996 the Company recorded $14,100 in
restructuring and related non-recurring charges pertaining to the Company's
decision to discontinue its long-term care operations, exit and consolidate
underperforming outpatient locations and reorganize certain administrative
functions. The Company decided to discontinue its long-term care operations due
to the cumulative effect of actions taken by Medicare intermediaries which have
significantly changed the operating environment, as well as the overall outlook
for providing behavioral health services to patients in skilled and unskilled
nursing homes. The annualized revenue run rate of the discontinued operations
was approximately $8,000 at December 31, 1996. During 1996, the Company also
completed implementation of the previous year's plan which reorganized certain
long-term care operations and reduced management and overhead costs.
Of the total restructuring and related non-recurring
charges, approximately $3,650 related to amounts to be paid in cash. The
non-cash portion of the charges relates to the write-off of certain assets,
principally goodwill associated with operations in geographic areas the Company
is exiting, and reserves established concurrently with the discontinuation of
providing long-term care services for denied claims, potential refunds and
associated costs.
Interest Expense
Interest expense increased to $763 in 1996 from $498 in
1995 due primarily to a higher average outstanding debt balance during 1996 than
in 1995. Interest expense decreased to $498 in 1995 from $641 in 1994 due
primarily to debt which was repaid after the Company's public offering in June
1994, partially offset by an increase in interest expense from acquisition
related debt which has increased as a result of the acquisitions in 1995 and
1994.
Interest Income
Interest income decreased to $116 in 1996 from $1,078 in
1995 due to a lower average outstanding investment portfolio balance during
1996. Interest income is primarily related to the Company's portfolio of
short-term investments. Interest income increased to $1,078 in 1995 compared to
$973 in 1994 due to a higher average outstanding investment portfolio balance
during 1995.
18
<PAGE> 22
Medicare Review
During 1996, certain of the Company's Medicare Part B
and related co-insurance billings previously submitted by one of Apogee's
subsidiaries were selected for review by the Office of the Inspector General of
the Department of Health and Human Services ("OIG") and the Department of
Justice ("DOJ"). Apogee has been informed by the DOJ that the review is a civil
matter relating to billings for services to Medicare patients in long term care
facilities in the State of Florida during the period from approximately January
1994 through mid-1995. During the pendency of this review, the Medicare
intermediary has suspended all Medicare payments to this subsidiary. It is the
Company's policy to comply with all federal, state and local laws including
those applicable to the Medicare program and the Company is fully cooperating
with the review. Due to the preliminary nature of the review, the Company cannot
predict when the review will be completed, its ultimate outcome, or its
potential impact on earnings but believes the outcome of the review, including
repayments, if any, should not have a material adverse impact on the Company's
financial condition.
Liquidity and Capital Resources
Net cash provided by operations was $2,531 in 1996,
compared to net cash provided by operations of $4,236 in 1995. The decrease in
net cash flows from operations was primarily due to an increase in the 1996 cash
portion of the restructuring and non-recurring charges. Cash and cash
equivalents decreased $9,650 due principally to payments for acquisitions of
businesses, principal payments on long term debt and purchases of property and
equipment. In 1996, the Company used $1,345 in cash for capital expenditures
compared with $2,515 in 1995.
At December 31, 1996, the Company's working capital was
($7,102) compared to $6,581 at December 31, 1995. The decrease in working
capital was principally a result of: 1) approximately $4,000 in current
liabilities at December 31, 1996 for accrued restructuring and related
non-recurring charges; 2) approximately $2,700 in reserves established for
denied claims, potential refunds and associated costs recorded concurrent with
the Company's exit of long-term care and certain outpatient clinic locations;
and 3) a combination of principal payments on subordinated debt, payment for
businesses acquired and related transaction costs and capital equipment.
In April, 1996, the Company entered into an agreement
with a bank establishing a two year revolving credit facility ("Credit
Facility") for up to a maximum of $15,000. Borrowings availability under this
Credit Facility are based on the Company's earnings before interest, income
taxes, depreciation and amortization, and the value of selected assets,
principally accounts receivable and property and equipment; subject to various
financial and non-financial covenants; and secured by substantially all of the
assets of the Company. Borrowings under this facility bear interest at the
bank's prime rate plus 1.0% or LIBOR plus 2.85%. The proceeds of this Credit
Facility are available for general corporate purposes, including working capital
and future acquisitions. Borrowings outstanding under the Credit Facility were
$5,650 at December 31, 1996. The Credit Facility was amended in March 1997 to
extend the maturity to June 30, 1998. The Amendment generally resets various
financial covenants to reflect the Company's restructuring and related
non-recurring charges incurred in 1996. In addition, the bank retains discretion
for borrowings in excess of $12,000.
19
<PAGE> 23
The Company's current ratio, working capital and debt to
equity ratio are set forth below for the dates indicated:
<TABLE>
<CAPTION>
December 31, 1996 December 31, 1995
---------------- -----------------
<S> <C> <C>
Current Ratio .70:1 1.28:1
Working Capital ($7,102) $6,581
Debt to equity .20:1 .14:1
</TABLE>
The Company believes that the cash flows generated by
the Company's operations, together with its existing cash and availability of
borrowings under the amended credit facility, will be sufficient to meet the
Company's cash requirements in 1997.
Inflation
A significant portion of the Company's operating
expenses have been subject to inflationary increases, including clinical and
administrative salaries. The Company has historically been able to somewhat
offset inflationary increases through charge increases, expanding services and
increasing operating efficiencies. There can be no assurance that the Company
will be able to offset future inflationary increases in expenses, if any.
CAUTIONARY STATEMENT
Matters discussed above contain forward-looking statements that are based on
management's estimates, assumptions and projections. Major factors which could
cause results to differ materially from those expected by management include the
timing and nature of reimbursement charges, the nature of changes in laws and
regulations that govern various aspects of the Company's business, new criteria
adopted to determine medical necessity for behavioral health service, the
outcome of Department of Justice review, changes in procedures by third party
payors, pricing of managed care and other third party contracts, the number and
productivity of clinicians, the direction and success of competitors, management
retention and unanticipated market changes. The Company does not undertake any
obligation to update the information contained herein, which speaks only as of
this date.
20
<PAGE> 24
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
APOGEE, INC.
CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
<TABLE>
<CAPTION>
DECEMBER 31,
-------------------------
ASSETS
1996 1995
--------- ---------
<S> <C> <C>
CURRENT ASSETS:
CASH AND CASH EQUIVALENTS $ 2,299 $ 11,949
ACCOUNTS RECEIVABLE, NET OF ALLOWANCE
FOR DOUBTFUL ACCOUNTS 11,096 14,555
OTHER ACCOUNTS RECEIVABLE 1,643 1,911
OTHER CURRENT ASSETS 1,407 1,471
--------- ---------
TOTAL CURRENT ASSETS 16,445 29,886
PROPERTY AND EQUIPMENT, NET 3,359 4,671
INTANGIBLE ASSETS AND EXCESS COST OVER FAIR VALUE
OF NET ASSETS ACQUIRED, NET 77,381 74,105
OTHER ASSETS 598 389
--------- ---------
$ 97,783 $ 109,051
========= =========
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
NOTE PAYABLE TO BANK $ 272
CURRENT PORTION OF LONG-TERM DEBT $ 4,584 5,226
ACCOUNTS PAYABLE 2,196 1,457
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 16,767 16,350
--------- ---------
TOTAL CURRENT LIABILITIES 23,547 23,305
LONG-TERM DEBT 8,224 5,748
OTHER LONG-TERM LIABILITIES 485 516
DEFERRED INCOME TAX LIABILITY 346 743
--------- ---------
TOTAL LIABILITIES 32,602 30,312
--------- ---------
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
COMMON STOCK, $.01 PAR VALUE, 20,000,000 SHARES
AUTHORIZED; ISSUED 9,822,570 IN 1996 AND
9,741,050 IN 1995 98 97
CAPITAL IN EXCESS OF PAR VALUE 85,624 85,612
ACCUMULATED DEFICIT (20,489) (6,895)
DEFERRED COMPENSATION (52) (75)
--------- ---------
TOTAL STOCKHOLDERS' EQUITY 65,181 78,739
--------- ---------
$ 97,783 $ 109,051
========= =========
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS
21
<PAGE> 25
APOGEE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<TABLE>
<CAPTION>
YEARS ENDED DECEMBER 31,
-----------------------------------------------
1996 1995 1994
----------- ----------- -----------
<S> <C> <C> <C>
NET REVENUES $ 78,727 $ 68,269 $ 33,473
COST OF REVENUES 61,402 51,495 25,711
----------- ----------- -----------
GROSS PROFIT 17,325 16,774 7,762
SELLING AND ADMINISTRATIVE EXPENSES 9,864 8,876 5,181
PROVISION FOR DOUBTFUL ACCOUNTS 3,886 3,408 1,784
AMORTIZATION OF INTANGIBLE ASSETS AND EXCESS
COST OVER FAIR VALUE OF NET ASSETS ACQUIRED 2,301 1,814 648
RESTRUCTURING CHARGE 9,650 5,600
OTHER NON-RECURRING CHARGES 4,450
----------- ----------- -----------
(LOSS) INCOME FROM OPERATIONS (12,826) (2,924) 149
NON-OPERATING EXPENSES (INCOME):
INTEREST EXPENSE - RELATED PARTIES 335
INTEREST EXPENSE - OTHER 763 498 306
INTEREST INCOME (116) (1,078) (973)
OTHER EXPENSES 30 19
----------- ----------- -----------
(LOSS) INCOME BEFORE INCOME TAXES (13,473) (2,374) 462
PROVISION FOR INCOME TAXES 121 77 75
----------- ----------- -----------
NET (LOSS) INCOME ($13,594) ($2,451) $ 387
=========== =========== ===========
NET (LOSS) INCOME PER COMMON SHARE ($1.37) ($0.26) $ 0.06
=========== =========== ===========
SHARES USED IN NET (LOSS) INCOME PER
COMMON SHARE COMPUTATION 9,887,362 9,497,279 6,883,215
=========== =========== ===========
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS
22
<PAGE> 26
APOGEE, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
( IN THOUSANDS)
<TABLE>
<CAPTION>
COMMON SHARES
-----------------------
CAPITAL IN
EXCESS OF ACCUMULATED DEFERRED
NUMBER PAR VALUE PAR VALUE DEFICIT COMPENSATION TOTAL
------- -------- -------- -------- ------- -------
<S> <C> <C> <C> <C> <C> <C>
BALANCE AT DECEMBER 31, 1993 4,045 $ 40 $ 364 ($ 4,831) ($4,427)
COMMON STOCK ISSUED IN CONNECTION WITH
ACQUISITIONS 358 4 4,730 4,734
COMMON STOCK ISSUED TO EMPLOYEES AND
DEFERRED COMPENSATION 24 196 ($117) 79
AMORTIZATION OF DEFERRED COMPENSATION 21 21
INITIAL PUBLIC OFFERING, NET OF ISSUANCE COSTS 4,850 49 73,718 73,767
NET INCOME 387 387
------- -------- -------- -------- ------- -------
BALANCE AT DECEMBER 31, 1994 9,277 93 79,008 (4,444) (96) 74,561
COMMON STOCK ISSUED IN CONNECTION WITH
ACQUISITIONS 458 4 6,491 6,495
EXERCISE OF STOCK OPTIONS 2 2
COMMON STOCK ISSUED FOR SERVICES RENDERED 6 111 111
AMORTIZATION OF DEFERRED COMPENSATION 21 21
NET LOSS (2,451) (2,451)
------- -------- -------- -------- ------- -------
BALANCE AT DECEMBER 31, 1995 9,741 97 85,612 (6,895) (75) 78,739
COMMON STOCK ISSUED IN CONNECTION WITH
ACQUISITIONS 122 1 743 744
COMMON STOCK REVERSAL (40) (731) (731)
AMORTIZATION OF DEFERRED COMPENSATION 23 23
NET LOSS (13,594) (13,594)
------- -------- -------- -------- ------- -------
BALANCE AT DECEMBER 31, 1996 9,823 $ 98 $ 85,624 ($20,489) ($52) $65,181
======= ======== ======== ======== ======= =======
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS
23
<PAGE> 27
APOGEE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
YEARS ENDED DECEMBER 31,
--------------------------------------
1996 1995 1994
-------- -------- --------
<S> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
NET (LOSS) INCOME ($13,594) ($ 2,451) $ 387
ADJUSTMENTS TO RECONCILE NET (LOSS) INCOME TO NET CASH
USED BY OPERATIONS:
DEPRECIATION AND AMORTIZATION 3,309 2,554 1,026
PROVISION FOR DOUBTFUL ACCOUNTS 3,886 3,408 1,784
NONCASH PORTION OF RESTRUCTURING AND
NONRECURRING CHARGE 11,507 4,400
CHANGES IN ASSETS AND LIABILITIES, NET OF
EFFECTS OF BUSINESSES ACQUIRED:
INCREASE IN ACCOUNTS RECEIVABLE (3,989) (6,211) (7,639)
INCREASE IN OTHER CURRENT ASSETS (548) (1,506) (604)
INCREASE (DECREASE) IN ACCOUNTS PAYABLE 739 603 (437)
INCREASE IN ACCRUED EXPENSES AND
OTHER CURRENT LIABILITIES 1,829 3,516 578
(DECREASE) INCREASE IN OTHER ASSETS
AND OTHER LIABILITIES (608) (77) 133
-------- -------- --------
NET CASH PROVIDED BY (USED IN) OPERATING
ACTIVITIES 2,531 4,236 (4,772)
-------- -------- --------
CASH FLOWS FROM INVESTING ACTIVITIES:
ACQUISITION OF BUSINESSES:
PAYMENTS FOR ACQUISITION OF BUSINESSES, NET OF
CASH ACQUIRED OF $524 IN 1996, $795 IN 1995
AND $668 IN 1994 (4,108) (10,102) (25,827)
ADDITIONAL PAYMENTS FOR BUSINESSES ACQUIRED
IN PRIOR YEARS (6,770) (5,964) (738)
-------- -------- --------
NET CASH OUTLAY FOR ACQUISITION OF BUSINESSES (10,878) (16,066) (26,565)
PURCHASES OF PROPERTY AND EQUIPMENT (1,345) (2,515) (1,724)
-------- -------- --------
NET CASH USED IN INVESTING ACTIVITIES (12,223) (18,581) (28,289)
-------- -------- --------
CASH FLOWS FROM FINANCING ACTIVITIES:
PROCEEDS FROM ISSUANCE OF COMMON STOCK 111 73,846
PROCEEDS FROM EXERCISE OF COMMON STOCK OPTIONS 2
PROCEEDS FROM ISSUANCE OF NOTES PAYABLE 6,650 275 11,492
PRINCIPAL PAYMENTS ON LONG-TERM OBLIGATIONS (6,608) (3,375) (22,073)
PAYMENTS FOR REDEMPTION OF MANDATORILY
REDEEMABLE PREFERRED STOCK (1,000)
-------- -------- --------
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 42 (2,987) 62,265
-------- -------- --------
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (9,650) (17,332) 29,204
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 11,949 29,281 77
-------- -------- --------
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 2,299 $ 11,949 $ 29,281
======== ======== ========
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
INTEREST PAID $ 694 $ 431 $ 588
======== ======== ========
INCOME TAXES PAID $ 234 $ 269 --
======== ======== ========
</TABLE>
THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS
24
<PAGE> 28
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except share and per share data)
NOTE 1 - ORGANIZATION AND OPERATION
Apogee, Inc. ("Apogee" or the "Company"), a Delaware Corporation,
was formed to provide behavioral health services and commenced operations on
March 15, 1991. The Company operates multi-disciplinary outpatient behavioral
health group practices and is one of the largest providers of outpatient
behavioral health services in the United States. Apogee provides behavioral
health and related services, principally at free-standing clinics. The Company
currently operates behavioral health clinics located in 13 states and the
District of Columbia. The Company also offers full and shared risk arrangements
with employers and managed care organizations to perform behavioral health
services on a capitated, sub-capitated and case rate basis. In addition, Apogee
provides an array of behavioral health services including: employee assistance
programs; third party clinical case management and claims adjudication; and
management and staffing of acute and sub-acute inpatient facilities,
correctional institutions and skilled nursing facilities through contractual
agreements. At December 31, 1996, Apogee's operations were principally
concentrated in California, Florida, Maryland, New Jersey, Pennsylvania,
Virginia and Wisconsin.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of consolidation
The consolidated financial statements include the accounts of the
Company and its wholly and beneficially owned subsidiaries. In response to
regulations in certain states in which the Company operates, it has executed
management agreements with professional corporations. Through the terms of the
management agreements, the Company has complete control over the professional
corporations with the exception of the provision or direction of behavioral
health services. The management agreements substantially restrict the business
activities and the rights of the shareholders of the professional corporations.
Under related agreements, the Company has the option to purchase, or to
designate a purchaser for, the stock of the professional corporations. These
professional corporations are consolidated because the Company has unilateral
and perpetual control over the assets and business operations of the
professional corporations and because, notwithstanding the lack of majority
ownership, consolidation of the professional corporations is necessary to
present fairly the financial position and results of operations of the Company
due to the existence of a parent-subsidiary relationship by means other than
majority ownership of the professional corporations' voting stock. The Company
effectively has perpetual control over the professional corporations because the
Company does not intend to terminate any of its management agreements with the
ongoing professional corporations and, upon termination of any such agreement by
the clinician, the Company intends to exercise its option to purchase or to
designate a purchaser for the stock of the professional corporation. Fees paid
to the Company under these agreements approximate the operating income, as
defined, of the beneficially owned subsidiaries. All significant intercompany
accounts and transactions have been eliminated.
Preparation of financial statements
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues
and expenses. Actual results could differ from those estimates.
Cash and cash equivalents
Cash and cash equivalents include cash on hand and short-term
investments with original maturities of 90 days or less. Revenue recognition
Revenue Recognition
Net revenues are reported at the estimated amounts to be realized
through payments from patients, third party payors and others for services
rendered.
25
<PAGE> 29
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
Property and equipment
Property and equipment are stated at cost less accumulated
depreciation and amortization. Additions and betterments are capitalized and
maintenance and repairs are charged to current operations. The cost of assets
retired or otherwise disposed of and the related accumulated depreciation and
amortization are removed from the accounts and the gain or loss on such
dispositions is reflected in current operations. Depreciation is provided using
the straight-line method. Estimated useful lives of the assets are:
<TABLE>
<S> <C>
Furniture and fixtures............................. 5 to 7 years
Office equipment................................... 3 to 5 years
</TABLE>
Intangible assets and excess cost over fair value of net assets acquired
Identifiable assets and liabilities acquired in connection with
business combinations accounted for under the purchase method are recorded at
their respective fair values. Deferred taxes have been recorded to the extent of
differences between the fair value and the tax basis of the assets acquired and
liabilities assumed. The excess of the purchase price over the fair value of the
identifiable net assets acquired is amortized on a straight-line basis over
forty years and identified intangible assets are amortized over periods ranging
from one to forty years. On an annual basis the Company reviews the
recoverability of goodwill based primarily on estimated future cash flows.
Accounting for Impairment of Long-Lived Assets
Effective January 1, 1996, the Company adopted Statement of
Financial Accounting Standards No. 121, "Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed of" ("SFAS 121"),
which establishes accounting standards for the impairment of long-lived assets,
certain identified intangible assets and goodwill related to those assets to be
held and used and for long-lived assets and certain intangible assets to be
disposed of. In accordance with SFAS 121, the Company reviews the realizability
of long-lived assets, certain intangible assets and goodwill whenever events or
circumstances occur which indicate recorded cost may not be recoverable. The
Company believes its previous impairment policy was substantially similar to the
new requirements and, accordingly, adoption of the new standard did not have a
significant effect on the Company's financial position or results of operations.
Financial Instruments
The carrying value of cash and cash equivalents, accounts receivable
and payable and accrued liabilities approximates fair value due to the
short-term maturities of these assets and liabilities.
Income taxes
The Company applies the asset and liability approach of Statement of
Financial Accounting Standards No. 109 for financial accounting and reporting of
income taxes and recognizes deferred tax assets and liabilities for the future
tax consequences of events that have been recognized in the Company's financial
statements or tax returns.
Net (loss) income per common share
Net loss per common share for 1996 and 1995 has been computed by
dividing net loss by the weighted average of common shares outstanding during
the year, giving effect to stock options, shares contingently payable in
connection with certain acquisitions and convertible debentures when dilutive.
26
<PAGE> 30
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
Net income per common share for 1994 has been computed by dividing
net income applicable to common shares by the weighted average of the number of
shares outstanding, giving effect to stock options, shares contingently payable
in connection with certain acquisitions and convertible debentures when
dilutive. Shares outstanding at June 7, 1994, the date of the Company's initial
public offering, have been treated as outstanding for all periods prior to that
date since all common shares issued through that date were issued at prices
significantly below the public offering price.
NOTE 3 - RECEIVABLES AND THIRD PARTY REIMBURSEMENTS
Accounts receivable consist of the following:
<TABLE>
<CAPTION>
December 31,
------------------------------
1996 1995
------- --------
<S> <C> <C>
Accounts receivable, net of contractual allowances $20,402 $ 22,607
Less: Allowance for doubtful accounts 9,306 8,052
------- --------
$11,096 $ 14,555
======= ========
</TABLE>
The Company's services are primarily reimbursed by third party
payors, including Medicare, Medicaid, managed care organizations and commercial
insurance companies. Approximately 16%, 21% and 37% of the Company's net
revenues for 1996, 1995 and 1994, respectively, were directly billed to Medicare
which is subject to Federal and state regulation. Third party reimbursement is
initially billed at "usual, customary and reasonable" market rates. Aggregate
billings are at established rates adjusted to estimated amounts realizable from
third party payors. The allowance for doubtful accounts is estimated based on an
ongoing review of collectibility.
NOTE 4 - BUSINESS ACQUISITIONS
During 1996, 1995 and 1994, the Company acquired 6, 19 and 14
businesses, respectively. These acquisitions have been accounted for using the
purchase method of accounting. The results of operations of the acquired
practices are included in the consolidated financial statements from the
respective dates of acquisition.
The following unaudited pro forma consolidated results of
operations of the Company, including the restructuring and other non-recurring
charges, give effect to each of the acquisitions as if they had occurred on
January 1, 1995:
<TABLE>
<CAPTION>
Years Ended December 31,
--------------------------------
1996 1995
---------- ---------
(Unaudited) (Unaudited)
<S> <C> <C>
Net revenues................................ $83,383 $89,108
Loss from operations........................ (12,391) (61)
Net loss ................................... (13,367) (29)
Net loss per common share................... ($1.35) $-----
</TABLE>
The above pro forma information is not necessarily indicative of the
results of operations that would have occurred had the acquisitions been made as
of the beginning of the respective periods or of the results which may occur in
the future.
27
<PAGE> 31
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
Information with respect to businesses acquired are as follows:
<TABLE>
<CAPTION>
December 31,
--------------------------------
1996 1995
------- -------
<S> <C> <C>
Intangible assets and excess cost over fair value of net
assets acquired........................................... $81,411 $76,425
Less: accumulated amortization............................... 4,030 2,320
------- -------
$77,381 $74,105
======= =======
</TABLE>
<TABLE>
<CAPTION>
Years Ended December 31,
---------------------------------
1996 1995 1994
---- ---- ----
<S> <C> <C> <C>
Cash paid (net of cash acquired) $ 4,108 $10,102 $25,827
Common stock issued .............................................. 191 5,424 4,734
Subordinated promissory notes issued ............................. 1,205 3,640 6,989
Convertible subordinated promissory notes issued ................. -- -- 2,550
Other deferred purchase price .................................... -- 1,570 --
------- ------- -------
5,504 20,736 40,100
Liabilities assumed .............................................. 819 3,329 4,863
------- ------- -------
6,323 24,065 44,963
Fair value of assets acquired, principally accounts
receivable, property and equipment and certain identified
intangible assets ................................................ 630 4,467 5,619
------- ------- -------
Cost in excess of fair value of net assets acquired $ 5,693 $19,598 $39,344
======= ======= =======
</TABLE>
In connection with certain acquisitions, the Company has entered
into contractual arrangements whereby additional shares of the Company's common
stock and cash may be issued to former owners of acquired companies upon
attainment of specified financial criteria over periods of two to four years as
set forth in the respective agreements. The number of shares of common stock to
be issued cannot be determined until the earn-out periods expire and the
attainment of criteria is established. If such criteria are attained, but not
exceeded, the Company will be obligated to make cash payments of approximately
$5,800 and issue approximately 490,000 shares of common stock over the next
three years. A lesser amount of cash would be paid and a lesser number of shares
of common stock would be issuable under certain acquisition agreements if the
financial criteria are not met and a greater amount of cash would be paid and a
greater number of shares of common stock would be issuable under certain
acquisition agreements if the financial criteria are exceeded. The Company paid
$2,829 and $1,492 in cash in 1996 and 1995, respectively, and issued 86,408 and
61,733 shares of common stock in 1996 and 1995, respectively in connection with
businesses acquired in prior years.
This consideration was accounted for as additional goodwill.
NOTE 5 - PROPERTY AND EQUIPMENT
<TABLE>
<CAPTION>
1996 1995
------- -------
<S> <C> <C>
Furniture, fixtures and equipment........................ $5,201 $5,796
Less: Accumulated depreciation.............. 1,842 1,125
------- -------
$3,359 $4,671
-====== -======
</TABLE>
Depreciation expense was $1,008, $791 and $357 for 1996, 1995 and
1994, respectively.
28
<PAGE> 32
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
NOTE 6 - BORROWINGS
Note payable to bank
Through April, 1996, the Company had a line of credit which allowed
borrowings up to the lesser of 75% of the Company's investments or $7,000 and
was collateralized by the Company's investments. Borrowings under this facility
at December 31, 1995 were $272 and bore interest at the bank's prime lending
rate. The note payable was repaid in April 1996.
In April 1996, the Company entered into an agreement with a bank
establishing a two year revolving credit facility ("Credit Facility") for up to
a maximum of $15,000. Borrowings availability under this Credit Facility are
based on the Company's earnings before interest, income taxes, depreciation and
amortization, and the value of selected assets, principally accounts receivable
and property and equipment; subject to various financial and non-financial
covenants; and secured by substantially all of the assets of the Company.
Borrowings under this facility bear interest at the bank's prime rate plus 1.0%
or LIBOR plus 2.85%. The weighted average interest rate on outstanding
borrowings at December 31, 1996 was 8.5%. The proceeds of this Credit Facility
are available for future acquisitions, working capital and general corporate
purposes. The Credit Facility was amended in March 1997 to extend the maturity
to June 30, 1998. The Amendment generally resets various financial covenants to
reflect the Company's restructuring and other non-recurring charges incurred in
1996. In addition, the bank retains discretion for borrowings in excess of
$12,000.
In 1994, the Company issued $2,550 of subordinated convertible
debentures at 5% - 6% in connection with business acquisitions. The debentures
are convertible, at the option of the holders, into shares of the Company's
common stock at conversion prices ranging from $16 to $18 a share. The
debentures are redeemable, in whole or in part, at the option of the Company.
There is no sinking fund applicable to the debentures.
<TABLE>
<CAPTION>
December 31,
---------------------
1996 1995
------ ------
<S> <C> <C>
Long- term debt
5.0% - 9.0% subordinated promissory notes issued in
connection with business acquisitions, payable
through 1999 ............................................................ $6,251 $ 8,586
Revolving credit facility (prime rate plus 1.0% or
LIBOR plus 2.85% expiring June 1998) .................................... 5,650 --
Subordinated convertible debentures, payable through 1997 .................. 825 2,204
Various installment loans payable through June 1998,
interest rates from 7.0% to 9.3% ........................................ 82 184
------- -------
12,808 10,974
Less: Amounts due within one year ............................. 4,584 5,226
------- -------
$ 8,224 $ 5,748
======= =======
Minimum repayments of long-term debt are:
1997............................................................ $4,584
1998 ........................................................... 7,487
1999 ........................................................... 737
-------
$12,808
=======
</TABLE>
The carrying amount of the Company's borrowings under its long-term
revolving credit facility approximates fair value. Based on the borrowing rates
currently available to the Company for loans with similar terms and maturity,
the fair value of the Company's remaining debt at December 31, 1996, and 1995
was $6,958 and $10,617, respectively.
29
<PAGE> 33
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
NOTE 7 - INCOME TAXES
The components of the provision for income tax expense for 1996,
1995 and 1994 are as follows:
<TABLE>
<CAPTION>
Years Ended December 31
--------------------------------------------
1996 1995 1994
---- ---- ----
<S> <C> <C> <C>
Current:
Federal............................................. $ 204 $41 $43
State............................................... 135 36 32
------ --- ---
339 77 75
------ --- ---
Deferred:
Federal............................................. (169) -- --
State............................................... (49) -- --
------ --- ----
(218) -- --
------ --- ----
$121 $77 $75
====== === ===
</TABLE>
Deferred tax assets (liabilities) comprise the following :
<TABLE>
<CAPTION>
December 31,
---------------------
1996 1995
------- -------
<S> <C> <C>
Net operating loss carryforwards ................................. $ 800 $ 118
Accruals and reserves not currently deductible
for tax purposes ............................................... 181 266
Restructuring reserve ............................................ 4,040 1,220
------- -------
Gross deferred tax assets ........................................ 5,021 1,604
------- -------
Valuation reserve ................................................ (5,021) (1,604)
------- -------
Total deferred tax assets ........................................ -- --
Temporary differences of acquired companies,
principally relating to cash to accrual conversion ............. (346) (743)
------- -------
Net deferred tax liabilities ..................................... ($ 346) ($ 743)
======= =======
</TABLE>
The reconciliation of the federal statutory tax rate to the
effective tax rate is as follows:
<TABLE>
<CAPTION>
Years Ended December 31,
----------------------------
1996 1995 1994
------ ------ -----
<S> <C> <C> <C>
Federal statutory tax rate ................................... (34%) (34%) 34%
State income taxes, less related federal tax benefit ......... (4) 2 4
Non-deductible amortization of excess cost over fair
value of net assets acquired ............................... 2 10 21
Business expense disallowance ................................ 2 2 --
Original issue discount ...................................... -- (4) --
Non-deductible portion of restructuring charge ............... 10 26 --
Valuation reserve ............................................ 25 28 115
Net operating losses utilized ................................ -- (27) (158)
--- --- ----
1% 3% 16%
=== === ====
</TABLE>
30
<PAGE> 34
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
At December 31, 1996, the Company had net operating loss
carryforwards for Federal income tax purposes of approximately $2,000. Their use
is limited to future taxable earnings of the Company and, as specified in the
Internal Revenue Code, use of certain of the net operating loss carryforwards is
limited as they were acquired by the Company in a purchase of the stock of other
companies. The carryforwards expire in varying amounts through 2010. A valuation
reserve has been established against the potential future benefit of the net
operating loss carryforwards.
NOTE 8 - RESTRUCTURING CHARGE
The components of the restructuring charges are as follows:
<TABLE>
<CAPTION>
Years Ended December 31,
----------------------------
1996 1995
------ -----
<S> <C> <C>
Write-down of assets ......................... $7,975 $4,400
Contract termination costs.................. 985 726
Employee severance costs.................. 690 474
------ ------
$9,650 $5,600
====== ======
</TABLE>
In December 1996, the Company recorded a provision for restructuring
pertaining to the Company's decision to discontinue the long term care
operations, exit and consolidate underperforming outpatient locations and
reorganize certain administrative functions. The write-down of assets includes a
goodwill impairment charge of $5,850 associated with operations in geographic
areas the Company is exiting. The remainder consists of fixed assets related to
restructured operations. Employee severance costs include the accumulation of
benefits set forth in the Company's severance policy which will be paid to 300
of the Company's employees who were terminated as a result of the restructuring
plan. The primary employee groups affected include those in long term care,
clinical and administrative personnel at certain clinic locations and regional
and corporate staff. The Company anticipates the restructuring plan will be
substantially completed by June 30, 1997.
During 1996, the Company also completed execution of the previous
year's plan which reorganized certain long term care operations and reduced
management and overhead costs. The Company completed the employee reduction
program by terminating 120 of the Company's employees and also wrote off assets
consisting primarily of goodwill in the amount of $1,850 and fixed assets of
$1,275.
At December 31, 1996, approximately $985 remained accrued for
contract termination costs, which consist primarily of costs for terminating
lease and other contractual arrangements, and $615 remained accrued for employee
severance costs. In March, 1997, the Company entered into a management agreement
and an agreement in principle with MHM Services, Inc., for the sale of the
Company's Pennsylvania and Tennessee long term care operations.
NOTE 9 - OTHER NON-RECURRING CHARGES
During 1996, two of the Company's principal Medicare Part B
Intermediaries adopted new payment review procedures for behavioral health
services performed in long term care facilities. The Company, both individually
and in conjunction with coalitions of behavioral healthcare providers, has
requested additional training and guidance on the revised payment review
standards. The Company believes it has been unable to obtain adequate training
and guidance on the new standards despite the fact the Intermediaries have been
applying the new review standards to the claims submitted by the Company. As
further described in Note 8, the Company has elected to discontinue its long
term care operations. The Company will continue to pursue collection of the
claims submitted to these Intermediaries, however, concurrent with the exit of
long term care, the Company has established a $3,200 reserve for denied claims,
potential refunds, and associated legal costs. In addition, the Company has
established a reserve of $1,250 for both long term care and clinic accounts
receivable which the Company believes will become impaired as a result of the
restructuring plan.
31
<PAGE> 35
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
NOTE 10 - COMMITMENTS AND CONTINGENCIES
Operating leases
The Company leases office and patient care facilities as well as
vehicles and equipment under noncancellable operating leases which require
future minimum annual rentals as follows:
<TABLE>
<S> <C>
1997..................................................... $3,752
1998..................................................... 2,813
1999..................................................... 2,294
2000..................................................... 1,428
2001..................................................... 489
2002 and thereafter...................................... 338
------
$11,114
=======
</TABLE>
Certain of the leases contain renewal options and escalation clauses
which require payments of additional rent to the extent of increases in related
operating costs. Rent expense was $3,800, $2,918 and $1,185 for the years ended
December 31, 1996, 1995 and 1994, respectively.
Capitated contracts
The Company has entered into agreements with managed care
organizations and corporations to provide behavioral health services to members
of a group at a fixed rate per member, regardless of the services actually
performed ("capitated contracts"). Approximately 18%, 16% and 10% of the
Company's net revenues were derived from capitated contracts in 1996, 1995 and
1994, respectively. Revenues under these contracts are recorded as earned and
expenses are recorded as incurred and include a reserve for service costs
incurred, but not reported. The Company estimates the costs of providing
services under these contracts by using historical experience and anticipated
utilization rates. The Company believes the future revenues under these
contracts will exceed the costs of services it will be required to provide under
the terms of the contracts. An underestimation of utilization of services under
these contracts could result in material losses to the Company. Generally,
either party to these capitated contracts may terminate the contract without
cause at any time with thirty to ninety days written notice.
Medicare Review
During 1996, certain of the Company's Medicare Part B and related
co-insurance billings previously submitted by one of Apogee's subsidiaries were
selected for review by the Office of the Inspector General of the Department of
Health and Human Services ("OIG") and the Department of Justice ("DOJ"). Apogee
has been informed by the DOJ that the review is a civil matter relating to
billings for services to Medicare patients in long term care facilities in the
State of Florida during the period from approximately January 1994 through
mid-1995. During the pendency of this review, the Medicare intermediary has
suspended all Medicare payments to this subsidiary. It is the Company's policy
to comply with all federal, state and local laws including those applicable to
the Medicare program and the Company is fully cooperating with the review. Due
to the preliminary nature of the OIG/DOJ review, the Company cannot predict when
the review will be completed, its ultimate outcome, or its potential impact on
earnings but believes the outcome of the OIG/DOJ review, including repayments,
if any, should not have a material adverse impact on the Company's financial
condition.
32
<PAGE> 36
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
NOTE 11 - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
<TABLE>
<CAPTION>
December 31,
------------------------------
1996 1995
------ ------
<S> <C> <C>
Clinician fees............................................ $3,019 $2,766
Acquisition related costs................................. 4,896 8,200
Salaries and vacation..................................... 1,989 2,258
Restructuring and other non-recurring costs............... 4,003 1,052
Other..................................................... 2,860 2,074
------ ------
$16,767 $16,350
======= =======
</TABLE>
NOTE 12 - STOCKHOLDERS' EQUITY
Prior to its initial public offering of common stock in 1994, the
Company sold 260,822 shares of common stock to officers, directors and employees
of the Company for $0.10 per share. In 1994, the Company issued 19,729 shares of
common stock to officers and employees of the Company as compensation at $4.00
per share.
On June 7, 1994 and July 7, 1994, the Company issued 4,500,000
shares and 349,500 shares of common stock, respectively, at $17 per share, in
connection with the initial public offering of its common stock. The net
proceeds of the offering were $73,767 after underwriters commissions and
expenses of the offering.
The Company has entered into stock purchase agreements with certain
of its directors and executive officers pursuant to which such individuals
purchased their respective shares of common stock. The stock purchase agreements
provide for the ownership of such shares to vest ratably over a five year
period. Unvested shares may be repurchased by the Company at their original
issue price in certain circumstances.
NOTE 13 - MANDATORILY REDEEMABLE PREFERRED STOCK
The Company's Board of Directors may, without further action of the
Company's stockholders, direct the issuance of shares of redeemable preferred
stock. Satisfaction of dividend preferences on preferred stock would reduce the
amount of funds available for the payment of dividends on the Company's common
stock. Holders of preferred stock would be entitled to preference payments in
the event of any liquidation, dissolution or winding-up of the Company. At
December 31, 1996, 10,000 of such shares were authorized and none were issued.
NOTE 14 - BENEFIT PLANS
Stock Option Plan
Effective April 19, 1994, the Company's Board of Directors ratified
and approved the establishment of an employee stock option plan ("the Plan")
under which options to purchase up to 400,000 shares of the Company's common
stock may be granted to employees, officers and directors. Each option granted
under the Plan must be exercised within a fixed period which may not exceed 10
years and may not be for a price which is less than the fair market value on the
date of grant. Options granted vest over four years and, at December 31, 1996,
the weighted average remaining contractual life of the outstanding options was
8.8 years.
33
<PAGE> 37
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
The following summarizes the activity of the stock option plan:
<TABLE>
<CAPTION>
Years Ended December 31,
-----------------------------------------
1996 1995 1994
---- ---- ----
Options:
<S> <C> <C> <C>
Outstanding at beginning of year ...................... 83,875 62,225 ---
Granted................................................ 104,350 39,750 62,225
Exercised.............................................. 200 150 ---
Canceled............................................... 30,855 17,950 ---
------- ------ ------
Outstanding at end of year............................. 157,170 83,875 62,225
======= ====== ======
Option Price Per Share Ranges:
Outstanding at beginning of year....................... $12.25-$14.75 $12.25 ---
Granted ............................................... $4.25 -$ 4.75 $12.25-$14.75 $12.25
Exercised ............................................. $4.75 $12.25
Outstanding at end of year ............................ $4.25-$14.75 $12.25-$14.75 $12.25
Options exercisable at end of year..................... 54,304 33,010 12,445
Exercisable option price ranges........................ $4.25 -$14.75 $12.25-$14.75 $12.25
Options available for grant at end of year under the
1994 Stock Option Plan ............................ 242,480 315,975 337,775
</TABLE>
The Company has adopted the disclosure-only provisions of
Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based
Compensation" ("SFAS 123"), but applies Accounting Principles Board Opinion No.
25 and related interpretations in accounting for the plan. The table below sets
forth the proforma information as if the Company had adopted the compensation
recognition provisions of SFAS 123:
<TABLE>
<CAPTION>
Years Ended
December 31,
----------------
1996 1995
---- ----
<S> <C> <C>
Increase to:
Net loss.................. $112 $50
Net loss per share........ $.01 ---
Assumptions:
Expected life (years)..... 4.0 4.0
Risk-free interest rate... 6.3% 5.1%
Volatility................ 40.0% 68.0%
Dividend yield............ N/A N/A
</TABLE>
The weighted average fair value of the stock options, calculated
using the Black-Scholes option pricing model, granted during the years ended
December 31, 1996 and 1995 is $1.78 and $8.13, respectively.
Retirement Plan
The Company has a defined contribution 401(k) plan covering
substantially all of its employees. In general, eligible employees may
contribute up to 6% of their compensation to this plan. Effective July 1, 1995,
employee contributions are matched at the rate of 15% and Company matching
contributions were $115 for 1996 and $49 for 1995.
34
<PAGE> 38
APOGEE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Dollars in thousands, except share and per share data)
NOTE 15- RELATED PARTY TRANSACTIONS
In 1994, the Company paid $850 to Foster Management Company for
its assistance in affecting the initial public offering of the Company's common
stock. With proceeds from the public offering, the Company repaid the 8%
promissory notes, the mandatorily redeemable preferred stock and accrued
interest payable to principal stockholders. Total payments in 1994 were $11,047.
Commencing July 1993, the Company leased space from an affiliated
entity. The rent expense under this lease is equal to the amount paid by the
affiliated party under the leasehold agreement and was $168, $104, and $102 for
1996, 1995 and 1994, respectively. In addition, the Company provides services
under an Employee Assistance Plan to an affiliated entity. The revenues from
this contract were $460, $519 and $56 in 1996, 1995 and 1994, respectively.
35
<PAGE> 39
REPORT OF INDEPENDENT ACCOUNTANTS
To the Shareholders and Board of Directors of
Apogee, Inc.
In our opinion, the consolidated financial statements listed in the index
appearing under Item 14(a)(1) and (2) on page 38 present fairly, in all material
respects, the financial position of Apogee, Inc. and its subsidiaries at
December 31, 1996 and 1995, and the results of their operations and their cash
flows for each of the three years in the period ended December 31, 1996, in
conformity with generally accepted accounting principles. These financial
statements are the responsibility of the Company's management; our
responsibility is to express an opinion on these financial statements based on
our audits. We conducted our audits of these statements in accordance with
generally accepted auditing standards which require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, and evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for the opinion expressed
above.
PRICE WATERHOUSE LLP
Philadelphia, PA
March 12, 1997
36
<PAGE> 40
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE - None
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE
REGISTRANT.
Information regarding the Company's executive officers is
contained in Part I under "Item 1. Business - Executive Officers of the
Company." Information regarding directors will be contained in the Company's
definitive Proxy Statement (the "Proxy Statement") for its 1997 annual meeting
of stockholders under the caption "Election of Directors" and is incorporated
herein by reference.
Section 16(a) of the Securities Exchange Act of 1934, as
amended, requires the Company's directors and executive officers, and persons
who own more than ten percent of the Company's common stock, to file with the
Securities and Exchange Commission (the "Commission") initial reports of
ownership and reports of changes in ownership of common stock. Such persons are
required by the Commission's regulations to furnish the Company with copies of
all Section 16(a) reports filed.
To the Company's knowledge, based solely on a review of the
copies of such reports furnished to the Company and representations that no
other reports were required, during the year ended December 31, 1996, all
Section 16(a) filing requirements applicable to its officers, directors and
greater than ten percent beneficial owners were complied with. However, John H.
Foster failed to make a timely filing statement on Form 4 regarding one
transaction during fiscal year 1994. Mr. Foster has subsequently filed a Form 5
reporting his transaction.
ITEM 11. EXECUTIVE COMPENSATION
For the information concerning this Item, see the table and
text under the captions "Executive Compensation", "Compensation of Directors",
"Compensation Committee Interlocks and Insider Participation" and "Employment
Arrangements" to be contained in the Proxy
Statement, which information is incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT.
For the information concerning this Item, see the table and
text under the caption "Information Concerning Certain Stockholders" to be
contained in the Proxy Statement, which information is incorporated herein by
reference.
37
<PAGE> 41
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
For the information concerning this Item, see the text under
the caption "Compensation Committee Interlocks and Insider Participation" and
"Certain Transactions" to be contained in the Proxy Statement, which information
is incorporated herein by reference.
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND
REPORTS ON FORM 8-K.
(a) The following documents are filed as part of this Report:
<TABLE>
<CAPTION>
Page
----
<S> <C>
(1) FINANCIAL STATEMENTS
Consolidated Balance Sheets as of December 31, 1996
and December 31, 1995................................................... 21
Consolidated Statements of Operations for the Years Ended
December 31, 1996, 1995 and 1994 ....................................... 22
Consolidated Statements of Changes in Stockholders' Equity
(Deficit) for the Years Ended December 31, 1996, 1995
and 1994................................................................ 23
Consolidated Statements of Cash Flows for the Years Ended
December 31, 1996, 1995 and 1994........................................ 24
Notes to Consolidated Financial Statements................................. 25
Report of Independent Accountants.......................................... 36
(2) FINANCIAL STATEMENT SCHEDULES
Schedule VIII Valuation and Qualifying Accounts............................ 41
(3) EXHIBITS
The exhibits required to be filed as part of this Annual Report on
Form 10-K are contained in the attached Index to Exhibits............... E-1
</TABLE>
(b) Current Reports on Form 8-K: (None)
(c) Exhibits required by Item 601 of Regulation S-K:
Exhibits required to be filed by the Company pursuant to Item
601 of Regulation S- K are contained in Exhibits listed in
response to Item 14(a)(3), and are incorporated herein by
reference.
38
<PAGE> 42
POWER OF ATTORNEY
The registrant and each person whose signature appears below
hereby appoint John H. Foster, Lawrence M. Davies and Alan N. Vinick as
attorneys-in-fact with full power of substitution, severally, to execute in the
name and on behalf of the registrant and each such person, individually and in
each capacity stated below, one or more amendments to the annual report which
amendments may make such changes in the report as the attorney-in-fact acting in
the premises deems appropriate and to file any such amendment to the report with
the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: March 28, 1997
APOGEE, INC.
By /s/ John H. Foster
----------------------------
John H. Foster
Chairman of the Board,
Chief Executive Officer
and Director
Pursuant to the requirements of the Securities and Exchange Act
of 1934, this report has been signed below by the following persons on behalf of
the registrant and in the capacities and on the dates indicated.
Dated: March 28, 1997
By /s/ John H. Foster
----------------------------
John H. Foster
Chairman of the Board
Chief Executive Officer
and Director
Dated: March 28, 1997
By /s/ Lawrence M. Davies
----------------------------
Lawrence M. Davies
President, Chief Operating
Officer and Director
39
<PAGE> 43
Dated: March 28, 1997
By /s/ Alan N. Vinick
----------------------------
Alan N. Vinick
Senior Vice President,
Finance and Chief Financial Officer
Dated: March 28, 1997
By /s/ Henry C. Dudley
----------------------------
Henry C. Dudley
Director
Dated: March 28, 1997
By /s/ Harvey V. Fineberg, M.D.
----------------------------
Harvey V. Fineberg, M.D.
Director
Dated: March 28, 1997
By /s/ Timothy E. Foster
----------------------------
Timothy E. Foster
Director
Dated: March 28, 1997
By /s/ Irwin Lehrhoff, Ph.D.
----------------------------
Irwin Lehrhoff, Ph.D.
Director
Dated: March 28, 1997
By /s/ R. Bruce Mosbacher
----------------------------
R. Bruce Mosbacher
Director
Dated: March 28, 1997
By /s/ Shawkat Raslan
----------------------------
Shawkat Raslan
Director
40
<PAGE> 44
SCHEDULE VIII
APOGEE, INC.
VALUATION AND QUALIFYING ACCOUNTS
Years ended December 31, 1996, 1995 and 1994
(Dollars in thousands)
<TABLE>
<CAPTION>
Additions
Balance at Additions Charged to Balance
Beginning Charged to Other at End
of Period Expenses (C) Accounts (B) Deductions (A) of Period
--------- ------------ ------------ -------------- ---------
<S> <C> <C> <C> <C> <C>
Description
Year ended December 31, 1996:
Allowance for doubtful accounts $8,052 6,586 200 5,532 $9,306
Year ended December 31, 1995:
Allowance for doubtful accounts $4,890 4,433 2,610 3,881 $8,052
Year ended December 31, 1994:
Allowance for doubtful accounts $ 335 1,784 3,948 1,177 $4,890
</TABLE>
- -------------------
(A) Write off of accounts deemed uncollectible.
(B) Represents the allowances for doubtful accounts acquired through the
purchases of businesses.
(C) Includes $2,700 and $1,025 in reserves established against receivables in
1996 and 1995, respectively, which were recorded in connection with the
Company's restructurings and other non recurring charges.
41
<PAGE> 45
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT PAGE
NUMBER EXHIBIT DESCRIPTION NUMBER
- ------ ------------------- ------
<S> <C> <C>
2(a) Agreement of Purchase and Sale dated as of July 1, 1994 by and among -------
Integra, Inc., Peter L. Brill, M.D. and the Company (incorporated by
reference to Exhibit 2(a) to the Company's Current Report on Form 8-K
dated July 31, 1994).
2(b) Agreement of Purchase and Sale dated as of September 1, 1994 by and -------
among Brea Mental Health Associates, Southern California Mental
Health Network Medical Group, Inc., Warren R. Taff, M.D., Gregg A.
Sentenn, M.D. and the Company (incorporated by reference to Exhibit 2
to the Company's Current Report on Form 8-K dated September 30, 1994).
2(c) Agreement to Purchase and Sale dated as of November 1, 1994 by and among -------
Metropolitan Psychiatric Group, Inc. ("MPG"), DOC Systems, Inc., the
partners of MPG and the Company (incorporated by reference to Exhibit
2(b) to the Company's Current Report on Form 8-K dated November 18,
1994).
2(d) Agreement and Plan of Reorganization dated as of October 1, 1995 by and -------
among Arista Behavioral Health, Inc., a New Jersey corporation, Arista
Counseling & Psychological Services, P.C., a New York professional
corporation, Arista Counseling & Psychological Services, P.C., a New
Jersey professional corporation, Apogee of Pennsylvania, Inc., a Delaware
corporation, the Company and Hadassah Gurfein, Ph.D. (incorporated by
reference to Exhibit 2 to the Company's Current Report on form 8-K dated
October 25, 1995).
3(a) Certificate of Incorporation to the Company as amended to date (incorporated -------
by reference to Exhibit 3(a) to the Company's Registration Statement on Form
S-1 (Registration No. 33-78034) filed with the Commission on April 22, 1994).
3(b) By-Laws of the Company (incorporated by reference to Exhibit 3(c) to the -------
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
4 Stock Option Plan (incorporated by reference to Exhibit 4 to the Company's -------
Registration Statement on Form S-1 (Registration No. 33-78034) filed with
the Commission on April 22, 1994).
</TABLE>
E-1
<PAGE> 46
<TABLE>
<CAPTION>
EXHIBIT PAGE
NUMBER EXHIBIT DESCRIPTION NUMBER
- ------ ------------------- ------
<S> <C> <C>
10(a) Stockholders Agreement dated March 15, 1991 between the Company and Irwin -------
Lehrhoff, individually and as trustee under the Irwin Lehrhoff Trust No. 1
(incorporated by reference to Exhibit 10(a) to the Company's Registration
Statement on Form S-1 (Registration No. 33-78034) filed with the Commission
on April 22, 1994).
10(b) Stock Purchase Agreement dated March 6, 1992 between the Company and -------
Lawrence M. Davies (incorporated by reference to Exhibit 10(g) to the
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
10(c) Stock Purchase Agreement dated March 6, 1992 between the Company and -------
Henry C. Dudley (incorporated by reference to Exhibit 10(h) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(d) Stock Purchase Agreement dated August 1, 1992 between the Company and -------
R. Bruce Mosbacher (incorporated by reference to Exhibit 10(i) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(e) Employment letter dated March 2, 1993 between the Company and Lawrence -------
M. Davies (incorporated by reference to Exhibit 10(j) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(f) Employment Letter dated May 13, 1993 between the Company and Jane P. -------
Stanton (incorporated by reference to Exhibit 10(m) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with
the Commission on April 22, 1994).
10(g) Stock Purchase Agreement dated June 21, 1993 between the Company and -------
Timothy E. Foster (incorporated by reference to Exhibit 10(n) to the
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
10(h) Stock Purchase Agreement dated June 22, 1993 between the Company and -------
Lawrence M. Davies (incorporated by reference to Exhibit 10(o) to the
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
</TABLE>
E-2
<PAGE> 47
<TABLE>
<CAPTION>
EXHIBIT PAGE
NUMBER EXHIBIT DESCRIPTION NUMBER
- ------ ------------------- ------
<S> <C> <C>
10(i) Stock Purchase Agreement dated July 1, 1993 between the Company and -------
Jane P. Stanton (incorporated by reference to Exhibit 10(p) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with
the Commission on April 22, 1994).
10(j) Employment Letter dated August 18, 1993 between the Company and Stanley -------
F. Szczygiel (incorporated by reference to Exhibit 10(q) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(k) Stock Purchase Agreement dated December 6, 1993 between the Company and -------
Harvey V. Fineberg, M.D. (incorporated by reference to Exhibit 10(u) to the
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
10(l) Employment Letter, dated December 17, 1993 between the Company and -------
Massoud G. Hampton, Ph.D. (incorporated by reference to Exhibit 10(v) to the
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
10(m) Stock Purchase Agreement dated January 10, 1994 between the Company and -------
Stanley F. Szczygiel (incorporated by reference to Exhibit 10(w) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(n) Consulting Agreement dated January 20, 1994 between the Company and Sean C. -------
McCrossen (incorporated by reference to Exhibit 10(x) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(o) Stock Purchase Agreement dated January 28, 1994 between the Company and -------
Shawkat Raslan (incorporated by reference to Exhibit 10(y) to the Company's
Registration Statement on Form S-1 (Registration No. 33-78034) filed with the
Commission on April 22, 1994).
10(p) Stock Purchase Agreement dated February 8, 1994 between the Company and -------
Massoud G. Hampton, Ph.D. (incorporated by reference to Exhibit 10(z) to the
Company's Registration Statement on Form S-1 (Registration No. 33-78034)
filed with the Commission on April 22, 1994).
</TABLE>
E-3
<PAGE> 48
<TABLE>
<CAPTION>
EXHIBIT PAGE
NUMBER EXHIBIT DESCRIPTION NUMBER
- ------ ------------------- ------
<S> <C> <C>
10(q) Stock Purchase Agreement dated February 22, 1994 between the Company and R. Bruce -------
Mosbacher, Trustee or Successor Trustee under the Mosbacher/Ditz Living Trust
U/A/D 8/30/93 (incorporated by reference to Exhibit 10 (ee) to the Company's
Registration Form S-1 (Registration No. 33-78034) filed with the Commission on
April 22, 1994).
10(r) Confidentiality and Non-Competition Agreement dated April 14, 1994 between -------
the Company and Massoud G. Hampton, Ph.D. (incorporated by reference to
Exhibit 10(v) to the Company's Registration Statement on Form S-1 (Registration
No. 33-78034) filed with the Commission on April 22, 1994).
10(s) Employment Letter dated January 30, 1996 by and between the Company and -------
Alan N. Vinick (incorporated by a reference to Exhibit 10(t) to the Company's
Annual Report on Form 10-K for the year ended December 31, 1995).
10(t) Credit agreement with PNC Bank, National Association dated on April 11, -------
1996 (incorporated by reference to the Company's current report on Form 8-K
dated April 11, 1996).
10(u) Amendment dated March 12, 1997 to credit agreement with PNC Bank, -------
National Association.
21 Subsidiaries of the Company. -------
23 Consent of Independent Accountants. -------
24 Powers of Attorney (See "Power of Attorney" in Form 10-K). -------
27 Financial Data Schedule, which is submitted electronically to the Securities -------
and Exchange Commission for information only and not filed.
</TABLE>
- ------------
(Note) Copies of Exhibits filed with this Annual Report on Form 10-K or
incorporated by reference herein do not accompany copies hereof for
distribution to stockholders of the Company. The Company will furnish a
copy of any of such exhibits to any stockholder requesting the same for
a nominal charge to cover duplicating costs.
E-4
<PAGE> 1
THIRD AMENDMENT TO LOAN AGREEMENT
This THIRD AMENDMENT TO LOAN AGREEMENT ("Amendment") dated as of March
12, 1997 is made by and among APOGEE, INC., a Delaware corporation ("Apogee")
and each Subsidiary identified on the attached Schedule 6.1(c) (collectively,
the "Borrowing Subsidiaries" and together with Apogee, the "Borrowers" and
individually, a "Borrower") and PNC BANK, NATIONAL ASSOCIATION, a national
banking association (the "Bank").
Reference is made to the Revolving Credit Agreement dated as of April
11, 1996 by and between the Borrowers and the Bank, as amended on June 21, 1996
and November 1, 1996 (the "Agreement") pursuant to which the Bank made available
to the Borrowers a $15,000,000 revolving credit facility. The obligations under
the Agreement and the Loan Documents were evidenced by the Borrowers' Note
payable to the Bank. (Capitalized terms used herein not otherwise defined shall
have the meanings provided for in the Agreement.)
The Borrowers and the Bank have agreed that the Agreement be amended as
provided herein, effective as of the date hereof, to provide for a new structure
of the Revolving Credit Commitment, eliminate all references to the Borrowing
Base and amend certain other provisions of the Agreement in connection
therewith.
NOW, THEREFORE, in consideration of the foregoing and for other
consideration, the receipt and sufficiency of which is hereby acknowledged, the
parties hereto, intending to be legally bound, hereby agree as follows:
<PAGE> 2
1. AMENDMENT TO AGREEMENT.
(a) Section 1.1 of the Agreement and the Agreement generally
(including without limitation, Section 2.5, 5.3 and 7.1 thereof) are hereby
amended by deleting the following definitions and all references to them:
Borrowing Base
Borrowing Base Certificate
(b) Section 1.1 of the Agreement is hereby further amended by
adding the following definitions:
Commitment Limit shall mean for any date in
any fiscal quarter, an amount equal to (x) Consolidated Cash
Flow from Operations for the prior twelve (12) month period
multiplied by (y) the ratio set forth in Section 8.2(n) in
respect of such quarter.
Discretionary Advance Sublimit shall have the
meaning given to such term in Section 2.1(b).
Revolving Credit Commitment shall mean the
lesser of (x) Fifteen Million Dollars ($15,000,000) and (y) the
Commitment Limit, subject in all respects to the Discretionary
Advance Sublimit.
(c) Section 1.1 of the Agreement is hereby further amended by
(i) amending and restating the definition of Expiration
Date to read in its entirety as follows: Expiration Date shall mean June 30,
1998;
(ii) by amending the definition of Consolidated Net
Income by adding at the end thereof a new sentence to read in its entirety as
follows:
For purposes of calculating the financial covenants in
Section 8.2(o), Consolidated Net Income for the fiscal
quarters ended March 31, 1996, June 30, 1996, September
30, 1996 and December 31, 1996 shall be deemed to be
$381,000, $710,000, $605,000 and
$(252,000) respectively.
<PAGE> 3
(iii) by amending the definition of Consolidated Cash
Flow From Operations by (x) inserting at the end of item (i), before the comma,
the phrase:
and for the fiscal quarter ended March 31, 1997 only,
an amount equal to $325,000 (which represents the loss
from discontinued operations) and (y) adding at the end
thereof the following phrase:
and for each of the four (4) fiscal quarters ending
March 31, 1996, June 30, 1996, September 30, 1996 and
December 31, 1996, shall be deemed to be $1,381,534,
$1,843,367, $1,715,030 and $607,046, respectively.
; and
(iv) by substituting in the definition of Minimum Net
Worth
Requirement for the phrase "$78,739,000" the phrase "$65,180,000."
(d) Section 2.1 of the Agreement is hereby amended and restated
to read in its entirety as follows:
(a) Subject to the terms and conditions hereof
(including, without limitation, subsection (b) hereof), and
relying upon the representations and warranties herein set
forth, the Bank agrees to make revolving credit loans (the
"Revolving Credit Loans") to any of the Borrowers at any time or
from time to time on or after the date hereof to, but not
including, the Expiration Date, in an aggregate principal amount
not to exceed at any one time the Bank's Revolving Credit
Commitment minus the aggregate undrawn face amount of
outstanding Letters of Credit issued pursuant to Section 2.9.
Within such limits of time and amount and subject to the other
provisions of this Agreement, the Borrowers may borrow, repay
and reborrow pursuant to this Section 2.1. Of the Revolving
Credit Commitment, an amount up to and including Twelve Million
Dollars ($12,000,000) shall be available, subject to the
provisions of this Agreement, for Revolving Credit Loans
irrespective of subsection (b) hereof.
(b) Revolving Credit Loans made under that portion of
the Revolving Credit Commitment in excess of Twelve Million
Dollars ($12,000,000) (such excess being the "Discretionary
Advance Sublimit") shall be made, if at all, at the sole
discretion of the Bank. The Bank may decline to make Loans under
the Discretionary Advance Sublimit at any time and for any
reason
<PAGE> 4
without prior notice to Apogee or any Borrower. The
Bank's willingness to consider making any Loan under
the Discretionary Advance Sublimit is subject to the
Bank's evaluation of the circumstances under which the
request for such Loan arises, the security and
collateral therefor, any credit support, guaranties or
credit enhancement to be provided in connection
therewith and other matters deemed appropriate by the
bank in its sole discretion. Unless otherwise agreed in
writing at the time any such Loan is made, the maturity
date of Loans outstanding under the Discretionary
Advance Sublimit shall be determined by the Bank at the
time such Loan is made and shall not be after the
Expiration Date.
(e) Section 5.3(b) of the Agreement is hereby amended
and restated to read in its entirety as follows:
The Borrowers shall by payment of money to the
Bank reduce the amount outstanding hereunder if and to
the extent it exceeds the Revolving Credit Commitment
as calculated using the most recently delivered
financial statements delivered pursuant to Section
8.1(m) or to the extent it exceeds amounts permitted by
the Bank to be outstanding under the Discretionary
Advance Sublimit. Such reductions shall be made within
five (5) Business Days after the Bank has provided
notice of the determination of such excess.
(f) Section 8.1(m)(v) of the Agreement is hereby
amended to delete references to the Borrowing Base and Exhibit 8.1(m)(v) is also
amended to delete references to, or provide for the calculation of, the
Borrowing Base.
(g) Section 8.2(k), relating to the current ratio, is
hereby deleted.
(h) Section 8.2(m) of the Agreement is hereby amended
by substituting for the table set forth therein the following table:
<PAGE> 5
<TABLE>
<CAPTION>
Period Ended Ratio
------------ -----
<S> <C> <C>
December 31, 1996 and 3.4
March 31, 1997
June 30, 1997 3.6
September 30, 199 3.5
December 31, 1997 and 3.0
thereafter
</TABLE>
(i) Section 8.2(n) of the Agreement is hereby
amended by (x) adding after the phrase "Indebtedness
under this Agreement" in item (i) the phrase: "except for
principal amounts not in excess of $12,000,000" and (y)
substituting for the table set forth therein the following
table:
<TABLE>
<CAPTION>
Period Ended Ratio
------------ -----
<S> <C> <C>
December 31, 1996 and 2.25
March 31, 1997
June 30, 1997 2.60
September 30, 1997 2.70
December 31, 1997 and 2.50
thereafter
</TABLE>
(j) Section 8.2(o) of the Agreement is hereby amended
by (x) inserting at the end of the item (A) after the phrase "income taxes" the
phrase:
and for the fiscal quarter ended March 31, 1997 only,
an amount equal to $325,000 (which represents the
loss from discontinued operations)
and (y) substituting for the table therein the following table:
<PAGE> 6
<TABLE>
<CAPTION>
Period Ended Ratio
------------ -----
<S> <C> <C>
December 31, 1996 and 2.10 to 1.0
March 31, 1997
June 30, 1997 1.3 to 1.0
September 30, 1997 0.8 to 1.0
December 31, 1997 and 1.4 to 1.0
thereafter
</TABLE>
2. MISCELLANEOUS.
(a) Recognizing and in consideration of the Bank's agreement
to the amendments herein set forth, the Borrowers hereby waive and release the
Bank and its officers, attorneys, agents, and employees from any liability,
suit, damage, claim, loss or expense of any kind or nature whatsoever and
howsoever arising out of or relating to the Bank's acts or omissions with
respect to the Revolving Credit Loans. The Borrowers further hereby agree to
indemnify and hold the Bank and its officers, attorneys, agents and employees
harmless from any loss, damage, judgment, liability or expense (including
counsel fees) suffered by or rendered against the Bank or any of them on account
of anything arising out of the Revolving Credit Note, the Credit Agreement, this
Agreement, the Loan Documents or any other document delivered pursuant thereto
up to and including the date hereof.
(b) All of the terms, conditions, provisions and covenants in
the Note, the Agreement, the Loan Documents, and all other documents delivered
to the Bank in connection with any of the foregoing documents and obligations
secured thereby shall remain unaltered and in full force and effect except as
modified by this Amendment.
<PAGE> 7
Amendment, including without limitation, the reasonable fees and expenses of the
Bank's counsel.
(d) This Amendment shall be governed by and construed in
accordance with the laws of the Commonwealth of Pennsylvania.
(e) Each and every one of the terms and provisions of this
Amendment shall be binding upon and shall inure to the benefit of the Borrowers
and the Bank and their respective successors and assigns.
(f) This Amendment may be executed in one or more
counterparts, each of which shall be deemed to be an original as against any
party whose signature appears thereon, and all of which shall constitute but one
and the same instrument.
(g) Apogee represents and warrants that all of its
subsidiaries are listed on the attached Schedule 6.1(c).
3. PAYMENT OF FEES.
Contemporaneously with the execution of this Amendment, Apogee shall
pay to the Bank (i) an amendment fee equal to $120,000 and (ii) at such time as
the first Loan, if any, under the Discretionary Advance Sublimit is made a fee
equal to $30,000. Such fee is not a commitment fee and is in consideration for
the Bank's underwriting and amendment to the Credit Agreement and the facilities
contemplated thereby and is not interest or a charge for the use of money.
<PAGE> 8
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
executed by their respective officers thereunto duly authorized as of the day
and year first above written.
APOGEE, INC., a Delaware corporation,
and each of the other BORROWERS
GUARANTORS listed on Schedule 6.1(c)
By: /s/ Alan N. Vinick
-------------------------------------
[Name], Alan N. Vinick
the Senior Vice Pres. [Title] of
each BORROWERS and GUARANTORS listed on
Schedule 6.1(c).
- and -
PNC BANK, NATIONAL ASSOCIATION
By: /s/ Marcie D. Knittel
-------------------------------------
Name: Marcie D. Knittel
Title: Vice President
<PAGE> 1
EXHIBIT 21
SUBSIDIARIES OF APOGEE, INC.
Advanced Behavioral Management
AGP Acquisition Corp.
Apogee of Northern Florida, Inc.
Apogee of Pennsylvania, Inc.
Apogee of Tennessee, Inc.
Apogee Health Services, Inc.
Apogee Services, Inc.
Associated Mental Health Services, Ltd.
Associates in Psychiatry, Inc.
DOC Systems, Inc.
Family Social and Psychotherapy Services, Inc.
InteCare Behavioral Services, L.L.C.
Integra IPA, Inc.
Martin E. Keller, Ed.D., Ltd.
Nevada Psychological Associates, Inc.
Naperville Psychiatric, Inc.
Psychiatric Associates, Inc.
Psychogeriatrics Consultants, Inc.
South Florida Substance Abuse, Inc.
Thunderbird Behavioral Health Institute, Inc.
Twin Ponds I, Inc.
Twin Ponds II, Inc.
Twin Ponds Management, Inc.
Winston Clinics, Inc.
Woodmont Psychiatric Associates, Inc.
<PAGE> 1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration
Statement on Form S-8 (No. 33-91660) of Apogee, Inc. of our report dated March
12, 1997 appearing on page 36 of this Form 10-K.
PRICE WATERHOUSE LLP
Philadelphia, PA
March 24, 1997
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AT DECEMBER 31, 1996 AND THE STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> DEC-31-1996
<CASH> 2,299
<SECURITIES> 0
<RECEIVABLES> 20,402
<ALLOWANCES> 9,306
<INVENTORY> 0
<CURRENT-ASSETS> 16,445
<PP&E> 5,201
<DEPRECIATION> 1,842
<TOTAL-ASSETS> 97,783
<CURRENT-LIABILITIES> 23,547
<BONDS> 8,224
0
0
<COMMON> 98
<OTHER-SE> 65,083
<TOTAL-LIABILITY-AND-EQUITY> 97,783
<SALES> 0
<TOTAL-REVENUES> 78,727
<CGS> 61,402
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 2,301
<LOSS-PROVISION> 3,886
<INTEREST-EXPENSE> 763
<INCOME-PRETAX> (13,473)
<INCOME-TAX> 121
<INCOME-CONTINUING> (13,594)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (13,594)
<EPS-PRIMARY> (1.37)
<EPS-DILUTED> (1.37)
</TABLE>
